syndrome	score	normalized_score
DUBOWITZ SYNDROME	0.06287355	100.0
GABRIELE-DE VRIES SYNDROME	0.05795674000000001	92.17984351130167
SIMPSON-GOLABI-BEHMEL SYNDROME	0.053557604	85.18304438034754
BECKWITH-WIEDEMANN SYNDROME	0.053012050000000005	84.31534405167197
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.052450314	83.42190635012656
1P36 DELETION SYNDROME	0.051790884	82.37308693401279
TRISOMY 8P	0.051245330000000006	81.50538660533722
HADDAD SYNDROME	0.051245330000000006	81.50538660533722
DEXTROCARDIA	0.050545554	80.39239712088786
MEDULLOBLASTOMA	0.050545554	80.39239712088786
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.050545554	80.39239712088786
NUT MIDLINE CARCINOMA	0.05	79.52469679221231
FAMILIAL COLORECTAL CANCER TYPE X	0.05	79.52469679221231
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.05	79.52469679221231
PARAGANGLIOMAS 4	0.05	79.52469679221231
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.05	79.52469679221231
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.05	79.52469679221231
LYNCH SYNDROME	0.05	79.52469679221231
PLATELET DISORDER, UNDEFINED	0.05	79.52469679221231
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.027118503999999998	43.13181616116793
9Q33.3Q34.11 MICRODELETION SYNDROME	0.02382682	37.896412720452396
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.0217663	34.61916815576661
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.021066524	33.50617867131727
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.020676729999999997	32.886213678088794
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.020407093999999997	32.45735925520349
DUBOWITZ SYNDROME	0.019861539999999997	31.589658926527925
NETHERTON SYNDROME; NETH	0.019161763999999998	30.47666944207858
16P13.2 MICRODELETION SYNDROME	0.019161763999999998	30.47666944207858
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.019040944	30.284505964749886
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.018616209999999998	29.60896911340301
48,XXXY SYNDROME	0.018612493999999997	29.60305883793741
RAYNAUD-CLAES SYNDROME; MRXSRC	0.017274224	27.474548518415137
22Q11.2 DELETION SYNDROME	0.016707734	26.573549608698727
48,XXYY SYNDROME	0.016707734	26.573549608698727
CHROMOSOME 18Q DELETION SYNDROME	0.016162179999999998	25.705849280023152
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.015873134	25.246123369843122
BARDET-BIEDL SYNDROME 1; BBS1	0.015600443999999998	24.81241157847775
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.015483340000000002	24.62615837661465
WEAVER SYNDROME	0.015479624	24.620248101149052
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.015213704000000002	24.197303953729353
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.015213704000000002	24.197303953729353
HELSMOORTEL-VAN DER AA SYNDROME	0.015213704000000002	24.197303953729353
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.015054889999999998	23.94471124980218
CORNELIA DE LANGE SYNDROME 1	0.01493407	23.75254777247348
MUCOPOLYSACCHARIDOSIS, TYPE II	0.014916849999999999	23.72515946689824
CLASSICAL EHLERS-DANLOS SYNDROME	0.014916849999999999	23.72515946689824
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.014355113999999999	22.831721765352835
48,XYYY SYNDROME	0.014355113999999999	22.831721765352835
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.013968374	22.216614140604435
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.013968374	22.216614140604435
47,XYY SYNDROME	0.013809559999999999	21.964021436677264
PRIMARY CILIARY DYSKINESIA	0.013809559999999999	21.964021436677264
49,XXXXY SYNDROME	0.013695683999999998	21.782902349239063
MYHRE SYNDROME	0.013574864	21.590738871910368
WITTEVEEN-KOLK SYNDROME	0.013419104000000001	21.343003536463268
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.013419104	21.343003536463264
MICROFORM HOLOPROSENCEPHALY	0.013150129999999998	20.91520202056349
ANGELMAN SYNDROME	0.01302931	20.723038543234797
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.012873550000000001	20.475303207787697
MENTAL RETARDATION, X-LINKED 90	0.012467574	19.82960084168939
BRAIN-LUNG-THYROID SYNDROME	0.012450353999999999	19.80221253611415
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.012450353999999999	19.80221253611415
OCULO-PALATO-CEREBRAL SYNDROME	0.012450353999999999	19.80221253611415
SECKEL SYNDROME 9; SCKL9	0.012450353999999999	19.80221253611415
IMMUNODEFICIENCY 23; IMD23	0.012450353999999999	19.80221253611415
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.012450353999999999	19.80221253611415
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.012450353999999999	19.80221253611415
NETHERTON SYNDROME	0.012450353999999999	19.80221253611415
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.012450353999999999	19.80221253611415
ALSTROM SYNDROME; ALMS	0.012450353999999999	19.80221253611415
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.012450353999999999	19.80221253611415
ALSTRÖM SYNDROME	0.012450353999999999	19.80221253611415
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.012450353999999999	19.80221253611415
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.012329534000000001	19.610049058785453
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.012173774	19.36231372333835
DIGEORGE SYNDROME; DGS	0.012173774	19.36231372333835
17Q23.1Q23.2 MICRODELETION SYNDROME	0.01192202	18.96190051301382
PERIPARTUM CARDIOMYOPATHY	0.011904799999999998	18.934512207438576
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.011904799999999998	18.934512207438576
AORTIC ARCH DEFECTS	0.011904799999999998	18.934512207438576
SYSTEMIC MASTOCYTOSIS	0.011904799999999998	18.934512207438576
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.011904799999999998	18.934512207438576
PGM3-CDG	0.011904799999999998	18.934512207438576
MYOTONIA PERMANENS	0.011904799999999998	18.934512207438576
BERNARD-SOULIER SYNDROME	0.011904799999999998	18.934512207438576
DERMATITIS, ATOPIC	0.011904799999999998	18.934512207438576
POTASSIUM-AGGRAVATED MYOTONIA	0.011904799999999998	18.934512207438576
CASPASE 8 DEFICIENCY	0.011904799999999998	18.934512207438576
EOSINOPHILIC GASTROENTERITIS	0.011904799999999998	18.934512207438576
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.011904799999999998	18.934512207438576
CUTANEOUS MASTOCYTOSIS	0.011904799999999998	18.934512207438576
CYSTIC FIBROSIS	0.011904799999999998	18.934512207438576
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	0.011904799999999998	18.934512207438576
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.011904799999999998	18.934512207438576
TRANSALDOLASE DEFICIENCY	0.011904799999999998	18.934512207438576
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.011904799999999998	18.934512207438576
CARCINOID SYNDROME	0.011904799999999998	18.934512207438576
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.011904799999999998	18.934512207438576
YAO SYNDROME	0.011904799999999998	18.934512207438576
ASTHMA, SUSCEPTIBILITY TO	0.011904799999999998	18.934512207438576
KERATOSIS PILARIS ATROPHICANS	0.011904799999999998	18.934512207438576
ICHTHYOSIS VULGARIS	0.011904799999999998	18.934512207438576
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.011904799999999998	18.934512207438576
STÜVE-WIEDEMANN SYNDROME	0.011904799999999998	18.934512207438576
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.011904799999999998	18.934512207438576
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.011904799999999998	18.934512207438576
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.011904799999999998	18.934512207438576
IMMUNODEFICIENCY 58; IMD58	0.011904799999999998	18.934512207438576
CHILBLAIN LUPUS	0.011904799999999998	18.934512207438576
IGE RESPONSIVENESS, ATOPIC	0.011904799999999998	18.934512207438576
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.011904799999999998	18.934512207438576
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.011904799999999998	18.934512207438576
NEUTROPHIL CHEMOTACTIC RESPONSE	0.011904799999999998	18.934512207438576
MASTOCYTOSIS	0.011904799999999998	18.934512207438576
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.011904799999999998	18.934512207438576
BRONCHIAL NEUROENDOCRINE TUMOR	0.011904799999999998	18.934512207438576
PRIMARY PULMONARY HYPOPLASIA	0.011904799999999998	18.934512207438576
MENKES DISEASE	0.011783980000000001	18.74234873010988
2Q33.1 DELETION SYNDROME	0.011783980000000001	18.74234873010988
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.011514344000000001	18.31349430722458
COFFIN-SIRIS SYNDROME 1; CSS1	0.011514344000000001	18.31349430722458
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.011514344000000001	18.31349430722458
TONNE-KALSCHEUER SYNDROME; TOKAS	0.011222244000000001	17.848911028564476
MONOSOMY 18P	0.011222244000000001	17.848911028564476
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.011222244000000001	17.848911028564476
LANDAU-KLEFFNER SYNDROME	0.011222244000000001	17.848911028564476
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01067669	16.981210699888905
FETAL ALCOHOL SYNDROME	0.010562814	16.800091612450704
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.010562814	16.800091612450704
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.010562814	16.800091612450704
SOTOS SYNDROME	0.010562814	16.800091612450704
WHITE-SUTTON SYNDROME; WHSUS	0.010562814	16.800091612450704
CHROMOSOME 16P13.2 DELETION SYNDROME	0.010407054	16.552356277003604
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.010407054	16.552356277003604
PHELAN-MCDERMID SYNDROME	0.010407054	16.552356277003604
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.010407054	16.552356277003604
DISTAL MONOSOMY 10Q	0.010407054	16.552356277003604
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.010407054	16.552356277003604
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.010407054	16.552356277003604
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.010407054	16.552356277003604
DISTAL MONOSOMY 15Q	0.010407053999999999	16.552356277003604
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.010407053999999999	16.552356277003604
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.010407053999999999	16.552356277003604
MONOSOMY 22Q13.3	0.010407053999999999	16.552356277003604
OGDEN SYNDROME	0.010269014	16.332804494099666
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.010269014	16.332804494099666
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.010269014	16.332804494099666
OGDEN SYNDROME; OGDNS	0.010269014	16.332804494099666
SYNDROMIC DIARRHEA	0.010269014	16.332804494099666
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.010269014	16.332804494099666
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.010269014	16.332804494099666
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.01001726	15.932391283775132
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.01001726	15.932391283775132
NANCE-HORAN SYNDROME	0.01001726	15.932391283775132
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.01001726	15.932391283775132
1Q41Q42 MICRODELETION SYNDROME	0.01001726	15.932391283775132
5Q14.3 MICRODELETION SYNDROME	0.0098615	15.684655948328032
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.0098615	15.684655948328032
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.0098615	15.684655948328032
PRADER-WILLI SYNDROME	0.0098615	15.684655948328032
COG5-CDG	0.0098615	15.684655948328032
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.00972346	15.465104165424092
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.00972346	15.465104165424092
VELOCARDIOFACIAL SYNDROME	0.00972346	15.465104165424092
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.00972346	15.465104165424092
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.009317484000000001	14.81940179932579
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.009317484000000001	14.81940179932579
HEREDITARY FOLATE MALABSORPTION	0.009317484000000001	14.81940179932579
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.009317484000000001	14.81940179932579
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.009317484000000001	14.81940179932579
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.009317484000000001	14.81940179932579
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.009317484000000001	14.81940179932579
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	14.81940179932579
ABETAL34V AMYLOIDOSIS	0.009317484000000001	14.81940179932579
20Q11.2 MICRODELETION SYNDROME	0.009317484000000001	14.81940179932579
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.009317484000000001	14.81940179932579
INFANTILE REFSUM DISEASE	0.009317484000000001	14.81940179932579
ARGININEMIA	0.009317484000000001	14.81940179932579
SHUKLA-VERNON SYNDROME; SHUVER	0.009161724	14.571666463878689
TETRASOMY 9P	0.009161724	14.571666463878689
HYPERPROLINEMIA, TYPE I	0.009161724	14.571666463878689
RING CHROMOSOME 22 SYNDROME	0.009161724	14.571666463878689
KLEEFSTRA SYNDROME 2; KLEFS2	0.009161724	14.571666463878689
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.009161724	14.571666463878689
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.009161724	14.571666463878689
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.009161724	14.571666463878689
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.009161724	14.571666463878689
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.009161724	14.571666463878689
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.009161724	14.571666463878689
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.009161724	14.571666463878689
HSD10 DISEASE	0.009161724	14.571666463878689
1P21.3 MICRODELETION SYNDROME	0.009161724	14.571666463878689
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009161724	14.571666463878689
COFFIN-SIRIS SYNDROME 2; CSS2	0.009161724	14.571666463878689
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.009161724	14.571666463878689
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.009161724	14.571666463878689
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.009161724	14.571666463878689
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.009161724	14.571666463878689
LUSCAN-LUMISH SYNDROME; LLS	0.009161724	14.571666463878689
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.009161724	14.571666463878689
KLEEFSTRA SYNDROME	0.009161724	14.571666463878689
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.009161724	14.571666463878689
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	13.95170147065022
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	13.95170147065022
RHEUMATIC FEVER	0.00877193	13.95170147065022
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00877193	13.95170147065022
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.00877193	13.95170147065022
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	13.95170147065022
CAFFEY DISEASE	0.00877193	13.95170147065022
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00877193	13.95170147065022
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	13.95170147065022
PFAPA SYNDROME	0.00877193	13.95170147065022
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	13.95170147065022
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	13.95170147065022
METACHROMATIC LEUKODYSTROPHY	0.00877193	13.95170147065022
LOCKED-IN SYNDROME	0.00877193	13.95170147065022
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	13.95170147065022
LESCH-NYHAN SYNDROME	0.00877193	13.95170147065022
HUNTINGTON DISEASE	0.00877193	13.95170147065022
ISOLATED CEREBELLAR AGENESIS	0.00877193	13.95170147065022
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	13.95170147065022
DIENCEPHALIC SYNDROME	0.00877193	13.95170147065022
5Q35 MICRODUPLICATION SYNDROME	0.00877193	13.95170147065022
NEUROFERRITINOPATHY	0.00877193	13.95170147065022
FAMILIAL DYSAUTONOMIA	0.00877193	13.95170147065022
CRYPTOCOCCOSIS	0.00877193	13.95170147065022
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00877193	13.95170147065022
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	13.95170147065022
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	13.95170147065022
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	13.95170147065022
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00877193	13.95170147065022
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	13.95170147065022
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	13.95170147065022
PINEOBLASTOMA	0.00877193	13.95170147065022
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	13.95170147065022
MILROY DISEASE	0.00877193	13.95170147065022
NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	13.95170147065022
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	13.95170147065022
KEIPERT SYNDROME	0.00877193	13.95170147065022
CORTICOBASAL SYNDROME	0.00877193	13.95170147065022
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	13.95170147065022
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	13.95170147065022
HISTIDINEMIA	0.00877193	13.95170147065022
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	13.95170147065022
PELIZAEUS-MERZBACHER DISEASE	0.00877193	13.95170147065022
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	13.95170147065022
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	13.95170147065022
SCLERODERMA	0.00877193	13.95170147065022
SNEDDON SYNDROME	0.00877193	13.95170147065022
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	13.95170147065022
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	13.95170147065022
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	13.95170147065022
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	13.95170147065022
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	13.95170147065022
HISTIDINEMIA	0.00877193	13.95170147065022
BREATH-HOLDING SPELLS	0.00877193	13.95170147065022
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	13.95170147065022
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00877193	13.95170147065022
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	13.95170147065022
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.00877193	13.95170147065022
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	13.95170147065022
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00877193	13.95170147065022
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00877193	13.95170147065022
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.00877193	13.95170147065022
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	13.95170147065022
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00877193	13.95170147065022
XQ12-Q13.3 DUPLICATION SYNDROME	0.00861617	13.703966135203116
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00861617	13.703966135203116
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.00861617	13.703966135203116
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.00861617	13.703966135203116
49,XXXYY SYNDROME	0.00861617	13.703966135203116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00861617	13.703966135203116
9Q21.13 MICRODELETION SYNDROME	0.00861617	13.703966135203116
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00861617	13.703966135203116
FRAXE INTELLECTUAL DISABILITY	0.00861617	13.703966135203116
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00861617	13.703966135203116
20Q13.33 MICRODELETION SYNDROME	0.00861617	13.703966135203116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00861617	13.703966135203116
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00861617	13.703966135203116
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.008502294	13.52284704776492
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.008502294	13.52284704776492
DOORS SYNDROME	0.008502294	13.52284704776492
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.008502294	13.52284704776492
CHROMOSOME 16P13.3 DELETION SYNDROME	0.008502294	13.52284704776492
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.008502294	13.52284704776492
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.008502294	13.52284704776492
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.008502294	13.52284704776492
PITT-HOPKINS SYNDROME	0.008502294	13.52284704776492
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.008502294	13.52284704776492
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.008502294	13.52284704776492
SMITH-LEMLI-OPITZ SYNDROME	0.008502294	13.52284704776492
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.008502294	13.52284704776492
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.008502294	13.52284704776492
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.008502294	13.52284704776492
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.008502294	13.52284704776492
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.008502294	13.52284704776492
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.008502294	13.52284704776492
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.008502294	13.52284704776492
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00795674	12.655146719089347
PROTEUS SYNDROME	0.00795674	12.655146719089347
KABUKI SYNDROME	0.00795674	12.655146719089347
QAZI-MARKOUIZOS SYNDROME	0.00795674	12.655146719089347
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00795674	12.655146719089347
SLC39A8-CDG	0.00795674	12.655146719089347
DUPLICATION/INVERSION 15Q11	0.00795674	12.655146719089347
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00795674	12.655146719089347
STURGE-WEBER SYNDROME	0.00795674	12.655146719089347
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00795674	12.655146719089347
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00795674	12.655146719089347
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00795674	12.655146719089347
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00795674	12.655146719089347
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.007256964	11.542157234640003
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.007256964	11.542157234640003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.007256964	11.542157234640003
OBESITY DUE TO SIM1 DEFICIENCY	0.007256964	11.542157234640003
MACROCEPHALY/AUTISM SYNDROME	0.007256964	11.542157234640003
DISTAL 16P11.2 MICRODELETION SYNDROME	0.007256964	11.542157234640003
PRADER-WILLI-LIKE SYNDROME	0.007256964	11.542157234640003
MENTAL RETARDATION, X-LINKED 107; MRX107	0.007256964	11.542157234640003
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.007256964	11.542157234640003
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.007256964	11.542157234640003
TIMOTHY SYNDROME; TS	0.007256964	11.542157234640003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.007256964	11.542157234640003
JOUBERT SYNDROME 10	0.007256964	11.542157234640003
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.007256964	11.542157234640003
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.007256964	11.542157234640003
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.007256964	11.542157234640003
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.007256964	11.542157234640003
XQ25 MICRODUPLICATION SYNDROME	0.007256964	11.542157234640003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.007256964	11.542157234640003
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.007256964	11.542157234640003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.007256964	11.542157234640003
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.007256964	11.542157234640003
COFFIN-SIRIS SYNDROME 5	0.007256964	11.542157234640003
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.007256964	11.542157234640003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.007256964	11.542157234640003
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.007256964	11.542157234640003
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.007256964	11.542157234640003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.007256964	11.542157234640003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.007256964	11.542157234640003
TURNPENNY-FRY SYNDROME; TPFS	0.007256964	11.542157234640003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.007256964	11.542157234640003
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.007256964	11.542157234640003
FRIED SYNDROME	0.007256964	11.542157234640003
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.007256964	11.542157234640003
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.007256964	11.542157234640003
CRANIOPHARYNGIOMA	0.007256964	11.542157234640003
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.007256964	11.542157234640003
FOLATE MALABSORPTION, HEREDITARY	0.007256964	11.542157234640003
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007256964	11.542157234640003
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.007256964	11.542157234640003
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.007256964	11.542157234640003
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.007256964	11.542157234640003
RABSON-MENDENHALL SYNDROME	0.007256964	11.542157234640003
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.007256964	11.542157234640003
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.007256964	11.542157234640003
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.007256964	11.542157234640003
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.007256964	11.542157234640003
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.007256964	11.542157234640003
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.007256964	11.542157234640003
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.007256964	11.542157234640003
MYOCLONIC-ASTASTIC EPILEPSY	0.007256964	11.542157234640003
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.007256964	11.542157234640003
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.007256964	11.542157234640003
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.007256964	11.542157234640003
SHWACHMAN-DIAMOND SYNDROME	0.007256964	11.542157234640003
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.007256964	11.542157234640003
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00671141	10.674456905964432
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.00671141	10.674456905964432
IMMUNODEFICIENCY 32A	0.00671141	10.674456905964432
SILVER-RUSSELL SYNDROME	0.00671141	10.674456905964432
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00671141	10.674456905964432
DRAVET SYNDROME	0.00671141	10.674456905964432
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00671141	10.674456905964432
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00671141	10.674456905964432
IMMUNODEFICIENCY 55; IMD55	0.00671141	10.674456905964432
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00671141	10.674456905964432
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.00671141	10.674456905964432
WALDENSTRÖM MACROGLOBULINEMIA	0.00671141	10.674456905964432
TUFTSIN DEFICIENCY	0.00671141	10.674456905964432
PSEUDODIASTROPHIC DYSPLASIA	0.00671141	10.674456905964432
IMMUNODEFICIENCY 52; IMD52	0.00671141	10.674456905964432
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.00671141	10.674456905964432
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00671141	10.674456905964432
PTEN HAMARTOMA TUMOR SYNDROME	0.00671141	10.674456905964432
NEURONAL INTESTINAL PSEUDOOBSTRUCTION	0.00671141	10.674456905964432
MICROPHTHALMIA, SYNDROMIC 1	0.00671141	10.674456905964432
RETT SYNDROME; RTT	0.00671141	10.674456905964432
IMMUNODEFICIENCY 37; IMD37	0.00671141	10.674456905964432
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.00671141	10.674456905964432
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8	0.00671141	10.674456905964432
46,XY SEX REVERSAL 9; SRXY9	0.00671141	10.674456905964432
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00671141	10.674456905964432
IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1	0.00671141	10.674456905964432
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00671141	10.674456905964432
HYPERTELORISM, TEEBI TYPE; TBHS	0.00671141	10.674456905964432
IMMUNE DEFICIENCY, FAMILIAL VARIABLE	0.00671141	10.674456905964432
LAZY LEUKOCYTE SYNDROME	0.00671141	10.674456905964432
NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	0.00671141	10.674456905964432
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.00671141	10.674456905964432
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00671141	10.674456905964432
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00671141	10.674456905964432
IDIOPATHIC APLASTIC ANEMIA	0.00671141	10.674456905964432
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00671141	10.674456905964432
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00671141	10.674456905964432
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00671141	10.674456905964432
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.00671141	10.674456905964432
MENTAL RETARDATION, X-LINKED 82	0.00671141	10.674456905964432
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00671141	10.674456905964432
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00671141	10.674456905964432
IMMUNODEFICIENCY 9; IMD9	0.00671141	10.674456905964432
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00671141	10.674456905964432
LICHTENSTEIN SYNDROME	0.00671141	10.674456905964432
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00671141	10.674456905964432
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00671141	10.674456905964432
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00671141	10.674456905964432
2Q24 MICRODELETION SYNDROME	0.00671141	10.674456905964432
SICKLE CELL ANEMIA	0.00671141	10.674456905964432
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00671141	10.674456905964432
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00671141	10.674456905964432
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00671141	10.674456905964432
WOLFRAM-LIKE SYNDROME	0.00671141	10.674456905964432
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.00671141	10.674456905964432
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00671141	10.674456905964432
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00671141	10.674456905964432
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.00671141	10.674456905964432
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00671141	10.674456905964432
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.00671141	10.674456905964432
3P25.3 MICRODELETION SYNDROME	0.00671141	10.674456905964432
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.00671141	10.674456905964432
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00671141	10.674456905964432
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.00671141	10.674456905964432
CHILDHOOD APRAXIA OF SPEECH	0.00671141	10.674456905964432
LENNOX-GASTAUT SYNDROME	0.00671141	10.674456905964432
CHRONIC GRAFT VERSUS HOST DISEASE	0.00671141	10.674456905964432
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.00671141	10.674456905964432
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.00671141	10.674456905964432
BULLOUS PEMPHIGOID	0.00671141	10.674456905964432
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00671141	10.674456905964432
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00671141	10.674456905964432
CONGENITAL ATRANSFERRINEMIA	0.00671141	10.674456905964432
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00671141	10.674456905964432
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.00671141	10.674456905964432
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.00671141	10.674456905964432
224250 DYSMYELINATION WITH JAUNDICE	0.00671141	10.674456905964432
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00671141	10.674456905964432
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00671141	10.674456905964432
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.00671141	10.674456905964432
UROCANIC ACIDURIA	0.00671141	10.674456905964432
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00671141	10.674456905964432
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00671141	10.674456905964432
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.00671141	10.674456905964432
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00671141	10.674456905964432
HISTIOCYTOSIS, FAMILIAL LIPOCHROME	0.00671141	10.674456905964432
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00671141	10.674456905964432
CYSTIC DISEASE OF LUNG	0.00671141	10.674456905964432
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.006707694	10.668546630498835
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.006707694	10.668546630498835
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.006707694	10.668546630498835
EMANUEL SYNDROME	0.006707694	10.668546630498835
EMANUEL SYNDROME	0.006707694	10.668546630498835
FG SYNDROME TYPE 1	0.006707694	10.668546630498835
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.006707694	10.668546630498835
2P15P16.1 MICRODELETION SYNDROME	0.006707694	10.668546630498835
CRI-DU-CHAT SYNDROME	0.00616214	9.800846301823263
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.00616214	9.800846301823263
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.005462364	8.68785681737392
15Q14 MICRODELETION SYNDROME	0.005462364	8.68785681737392
DE BARSY SYNDROME	0.005462364	8.68785681737392
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.005462364	8.68785681737392
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.005462364	8.68785681737392
GLASS SYNDROME	0.005462364	8.68785681737392
WRINKLY SKIN SYNDROME	0.005462364	8.68785681737392
CHROMOSOME 9P DELETION SYNDROME	0.005462364	8.68785681737392
SIALIDOSIS TYPE 2	0.005462364	8.68785681737392
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.005462364	8.68785681737392
20Q11.2 MICRODUPLICATION SYNDROME	0.005462364	8.68785681737392
BARATELA-SCOTT SYNDROME	0.005462364	8.68785681737392
ASPARTYLGLUCOSAMINURIA	0.00491681	7.8201564886983475
SMITH-FINEMAN-MYERS SYNDROME	0.00491681	7.8201564886983475
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00491681	7.8201564886983475
ADNP SYNDROME	0.00491681	7.8201564886983475
7Q11.23 MICRODUPLICATION SYNDROME	0.00491681	7.8201564886983475
SHORT SYNDROME	0.00491681	7.8201564886983475
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.004802934	7.639037401260149
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004802934	7.639037401260149
ARTERIAL TORTUOSITY SYNDROME	0.004802934	7.639037401260149
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.004802934	7.639037401260149
2Q31.1 MICRODELETION SYNDROME	0.004802934	7.639037401260149
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.004802934	7.639037401260149
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.004802934	7.639037401260149
1Q21.1 MICRODELETION SYNDROME	0.004802934	7.639037401260149
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.004802934	7.639037401260149
JACOBSEN SYNDROME	0.004802934	7.639037401260149
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.004802934	7.639037401260149
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.004802934	7.639037401260149
AARSKOG-SCOTT SYNDROME	0.004802934	7.639037401260149
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.004802934	7.639037401260149
BOHRING-OPITZ SYNDROME	0.004802934	7.639037401260149
15Q24 MICRODELETION SYNDROME	0.004802934	7.639037401260149
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00425738	6.7713370725845765
FOCAL DERMAL HYPOPLASIA; FDH	0.00425738	6.7713370725845765
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00425738	6.7713370725845765
WILLIAMS-BEUREN SYNDROME; WBS	0.00425738	6.7713370725845765
ACROCALLOSAL SYNDROME; ACLS	0.00425738	6.7713370725845765
SCHWARTZ-JAMPEL SYNDROME	0.00425738	6.7713370725845765
FEMORAL-FACIAL SYNDROME	0.00425738	6.7713370725845765
SCARF SYNDROME	0.00425738	6.7713370725845765
SCARF SYNDROME	0.00425738	6.7713370725845765
FOCAL DERMAL HYPOPLASIA	0.00425738	6.7713370725845765
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00425738	6.7713370725845765
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.00425738	6.7713370725845765
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00425738	6.7713370725845765
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00425738	6.7713370725845765
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00425738	6.7713370725845765
MARDEN-WALKER SYNDROME	0.00425738	6.7713370725845765
PALLISTER-KILLIAN SYNDROME	0.00425738	6.7713370725845765
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00425738	6.7713370725845765
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00425738	6.7713370725845765
OCULOCEREBRORENAL SYNDROME OF LOWE	0.00425738	6.7713370725845765
GM1 GANGLIOSIDOSIS	0.00425738	6.7713370725845765
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00425738	6.7713370725845765
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00425738	6.7713370725845765
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00425738	6.7713370725845765
WILLIAMS SYNDROME	0.00425738	6.7713370725845765
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00425738	6.7713370725845765
TRISOMY 20P	0.00425738	6.7713370725845765
FLOATING-HARBOR SYNDROME	0.00425738	6.7713370725845765
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00425738	6.7713370725845765
SHPRINTZEN-GOLDBERG SYNDROME	0.00425738	6.7713370725845765
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00425738	6.7713370725845765
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00425738	6.7713370725845765
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00425738	6.7713370725845765
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00425738	6.7713370725845765
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0036956439999999997	5.877899371039173
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0036956439999999997	5.877899371039173
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0036956439999999997	5.877899371039173
16P11.2P12.2 MICRODELETION SYNDROME	0.0036956439999999997	5.877899371039173
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.0036956439999999997	5.877899371039173
2Q32Q33 MICRODELETION SYNDROME	0.0036956439999999997	5.877899371039173
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0036956439999999997	5.877899371039173
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0036956439999999997	5.877899371039173
ADENYLOSUCCINASE DEFICIENCY	0.0036956439999999997	5.877899371039173
1Q44 MICRODELETION SYNDROME	0.0036956439999999997	5.877899371039173
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.0036956439999999997	5.877899371039173
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.0036956439999999997	5.877899371039173
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.0036956439999999997	5.877899371039173
CHROMOSOME 10Q26 DELETION SYNDROME	0.0036956439999999997	5.877899371039173
CHROMOSOME 1P36 DELETION SYNDROME	0.0036956439999999997	5.877899371039173
MEHMO SYNDROME; MEHMO	0.0036956439999999997	5.877899371039173
11Q22.2Q22.3 MICRODELETION SYNDROME	0.0036956439999999997	5.877899371039173
DESANTO-SHINAWI SYNDROME	0.0036956439999999997	5.877899371039173
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0036956439999999997	5.877899371039173
KOOLEN-DE VRIES SYNDROME; KDVS	0.0036956439999999997	5.877899371039173
CK SYNDROME	0.0036956439999999997	5.877899371039173
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.0036956439999999997	5.877899371039173
19P13.12 MICRODELETION SYNDROME	0.0036956439999999997	5.877899371039173
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.0036956439999999997	5.877899371039173
6Q16 MICRODELETION SYNDROME	0.0036956439999999997	5.877899371039173
DISTAL MONOSOMY 6P	0.0036956439999999997	5.877899371039173
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0036956439999999997	5.877899371039173
COFFIN-SIRIS SYNDROME 7; CSS7	0.0036956439999999997	5.877899371039173
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.0036956439999999997	5.877899371039173
6Q TERMINAL DELETION SYNDROME	0.0036956439999999997	5.877899371039173
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0036956439999999997	5.877899371039173
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.0036956439999999997	5.877899371039173
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.0036956439999999997	5.877899371039173
SMITH-MAGENIS SYNDROME	0.0036956439999999997	5.877899371039173
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0036956439999999997	5.877899371039173
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0036956439999999997	5.877899371039173
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0036956439999999997	5.877899371039173
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0036956439999999997	5.877899371039173
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0036956439999999997	5.877899371039173
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0036956439999999997	5.877899371039173
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0036956439999999997	5.877899371039173
GABRIELE-DE VRIES SYNDROME; GADEVS	0.0036956439999999997	5.877899371039173
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0036956439999999997	5.877899371039173
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0036956439999999997	5.877899371039173
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0036956439999999997	5.877899371039173
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0036956439999999997	5.877899371039173
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.0036956439999999997	5.877899371039173
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.0036956439999999997	5.877899371039173
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0036956439999999997	5.877899371039173
CHROMOSOME 19P13.13 DELETION SYNDROME	0.0036956439999999997	5.877899371039173
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0036956439999999997	5.877899371039173
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.0036956439999999997	5.877899371039173
PIERPONT SYNDROME	0.0036956439999999997	5.877899371039173
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0036956439999999997	5.877899371039173
LAMB-SHAFFER SYNDROME	0.0036956439999999997	5.877899371039173
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.0036956439999999997	5.877899371039173
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.0036956439999999997	5.877899371039173
8Q24.3 MICRODELETION SYNDROME	0.003557604	5.658347588135233
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.003557604	5.658347588135233
OROFACIODIGITAL SYNDROME XVI; OFD16	0.003557604	5.658347588135233
AYMÉ-GRIPP SYNDROME	0.003557604	5.658347588135233
CHROMOSOME 15Q25 DELETION SYNDROME	0.003557604	5.658347588135233
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.003557604	5.658347588135233
PALLISTER-HALL SYNDROME	0.003557604	5.658347588135233
PSEUDOAMINOPTERIN SYNDROME	0.003557604	5.658347588135233
ALPHA-MANNOSIDOSIS	0.003557604	5.658347588135233
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.003557604	5.658347588135233
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.003557604	5.658347588135233
17P13.3 MICRODUPLICATION SYNDROME	0.003557604	5.658347588135233
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.003557604	5.658347588135233
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.003557604	5.658347588135233
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.003557604	5.658347588135233
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.003557604	5.658347588135233
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.003557604	5.658347588135233
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.003557604	5.658347588135233
3C SYNDROME	0.003557604	5.658347588135233
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.003557604	5.658347588135233
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.003557604	5.658347588135233
HYPEREKPLEXIA 4; HKPX4	0.003557604	5.658347588135233
PETERS PLUS SYNDROME	0.003557604	5.658347588135233
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.003557604	5.658347588135233
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.003557604	5.658347588135233
OCCIPITAL HORN SYNDROME	0.003557604	5.658347588135233
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.003557604	5.658347588135233
CUTIS LAXA	0.003557604	5.658347588135233
N-ACETYLASPARTATE DEFICIENCY; NACED	0.003557604	5.658347588135233
MUCOPOLYSACCHARIDOSIS TYPE 2	0.003557604	5.658347588135233
CATEL-MANZKE SYNDROME; CATMANS	0.003557604	5.658347588135233
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.003557604	5.658347588135233
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.003557604	5.658347588135233
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.003557604	5.658347588135233
DIAPHANOSPONDYLODYSOSTOSIS	0.003557604	5.658347588135233
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.003557604	5.658347588135233
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.003557604	5.658347588135233
VASCULAR EHLERS-DANLOS SYNDROME	0.003557604	5.658347588135233
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.003557604	5.658347588135233
WEAVER SYNDROME	0.003557604	5.658347588135233
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.003557604	5.658347588135233
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.003557604	5.658347588135233
KAGAMI-OGATA SYNDROME	0.003557604	5.658347588135233
RUVALCABA SYNDROME	0.003557604	5.658347588135233
PERLMAN SYNDROME	0.003557604	5.658347588135233
LATERAL MENINGOCELE SYNDROME	0.003557604	5.658347588135233
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.003557604	5.658347588135233
HURLER SYNDROME	0.003557604	5.658347588135233
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.003557604	5.658347588135233
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.003557604	5.658347588135233
KAGAMI-OGATA SYNDROME	0.003557604	5.658347588135233
SOTOS SYNDROME 2	0.00315009	5.010199042363602
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.00315009	5.010199042363602
MEIER-GORLIN SYNDROME 6; MGORS6	0.00315009	5.010199042363602
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00315009	5.010199042363602
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00315009	5.010199042363602
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00315009	5.010199042363602
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00315009	5.010199042363602
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00315009	5.010199042363602
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00315009	5.010199042363602
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00315009	5.010199042363602
4Q21 MICRODELETION SYNDROME	0.00315009	5.010199042363602
16Q24.3 MICRODELETION SYNDROME	0.00315009	5.010199042363602
MUCOLIPIDOSIS TYPE III	0.00301205	4.790647259459662
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00301205	4.790647259459662
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00301205	4.790647259459662
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00301205	4.790647259459662
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00301205	4.790647259459662
BLADDER EXSTROPHY	0.00301205	4.790647259459662
MARFAN SYNDROME	0.00301205	4.790647259459662
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00301205	4.790647259459662
VACTERL WITH HYDROCEPHALUS	0.00301205	4.790647259459662
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00301205	4.790647259459662
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00301205	4.790647259459662
LEPRECHAUNISM	0.00301205	4.790647259459662
LAMBERT SYNDROME	0.00301205	4.790647259459662
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00301205	4.790647259459662
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00301205	4.790647259459662
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.00301205	4.790647259459662
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00301205	4.790647259459662
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00301205	4.790647259459662
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00301205	4.790647259459662
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00301205	4.790647259459662
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00301205	4.790647259459662
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00301205	4.790647259459662
ACROCALLOSAL SYNDROME	0.00301205	4.790647259459662
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.00301205	4.790647259459662
LAMBERT SYNDROME	0.00301205	4.790647259459662
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00301205	4.790647259459662
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00301205	4.790647259459662
SCHINZEL-GIEDION SYNDROME	0.00301205	4.790647259459662
FRANK-TER HAAR SYNDROME	0.00301205	4.790647259459662
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00301205	4.790647259459662
MICROSPHEROPHAKIA WITH HERNIA	0.00301205	4.790647259459662
MUCOPOLYSACCHARIDOSIS TYPE 3	0.00301205	4.790647259459662
OSTEOGLOSPHONIC DYSPLASIA	0.00301205	4.790647259459662
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00301205	4.790647259459662
ACHONDROGENESIS	0.00301205	4.790647259459662
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00301205	4.790647259459662
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00301205	4.790647259459662
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00301205	4.790647259459662
X-LINKED EHLERS-DANLOS SYNDROME	0.00301205	4.790647259459662
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00301205	4.790647259459662
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.00301205	4.790647259459662
AMYLOIDOSIS	0.00301205	4.790647259459662
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00301205	4.790647259459662
BRITTLE CORNEA SYNDROME 2; BCS2	0.00301205	4.790647259459662
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00301205	4.790647259459662
WIDOW'S PEAK SYNDROME	0.00301205	4.790647259459662
ANDROGEN INSENSITIVITY SYNDROME	0.00301205	4.790647259459662
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00301205	4.790647259459662
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.00301205	4.790647259459662
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00301205	4.790647259459662
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00301205	4.790647259459662
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00301205	4.790647259459662
COFFIN-LOWRY SYNDROME; CLS	0.00301205	4.790647259459662
ACROOSTEOLYSIS DOMINANT TYPE	0.00301205	4.790647259459662
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00301205	4.790647259459662
EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	0.00301205	4.790647259459662
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00301205	4.790647259459662
HERNIA, DOUBLE INGUINAL	0.00301205	4.790647259459662
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00301205	4.790647259459662
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00301205	4.790647259459662
LATERAL MENINGOCELE SYNDROME	0.00301205	4.790647259459662
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00301205	4.790647259459662
FACIOCARDIORENAL SYNDROME	0.00301205	4.790647259459662
EHLERS-DANLOS SYNDROME, TYPE VI	0.00301205	4.790647259459662
OSTEOGENESIS IMPERFECTA	0.00301205	4.790647259459662
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00301205	4.790647259459662
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00301205	4.790647259459662
ARTERIAL TORTUOSITY SYNDROME	0.00301205	4.790647259459662
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00301205	4.790647259459662
LOEYS-DIETZ SYNDROME 3; LDS3	0.00301205	4.790647259459662
MONOSOMY 5P	0.00301205	4.790647259459662
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.00301205	4.790647259459662
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00301205	4.790647259459662
OSTEOGENESIS IMPERFECTA, TYPE X	0.00301205	4.790647259459662
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00301205	4.790647259459662
HYPEREKPLEXIA 1; HKPX1	0.00301205	4.790647259459662
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.00301205	4.790647259459662
NEURAMINIDASE DEFICIENCY	0.00301205	4.790647259459662
PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II	0.00301205	4.790647259459662
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00301205	4.790647259459662
ULNAR-MAMMARY SYNDROME; UMS	0.00301205	4.790647259459662
DIPHALLIA	0.00301205	4.790647259459662
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00301205	4.790647259459662
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.00301205	4.790647259459662
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00301205	4.790647259459662
SIMOSA CRANIOFACIAL SYNDROME	0.00301205	4.790647259459662
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00301205	4.790647259459662
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00301205	4.790647259459662
EXSTROPHY OF BLADDER	0.00301205	4.790647259459662
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00301205	4.790647259459662
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00301205	4.790647259459662
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00301205	4.790647259459662
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00301205	4.790647259459662
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.00301205	4.790647259459662
ANDROGEN INSENSITIVITY SYNDROME	0.00301205	4.790647259459662
ADAMS-OLIVER SYNDROME 5; AOS5	0.00301205	4.790647259459662
ISOLATED HEMIHYPERPLASIA	0.00301205	4.790647259459662
268650 RUDIGER SYNDROME	0.00301205	4.790647259459662
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00301205	4.790647259459662
RHINY	0.00301205	4.790647259459662
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00301205	4.790647259459662
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00301205	4.790647259459662
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.00301205	4.790647259459662
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00301205	4.790647259459662
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00301205	4.790647259459662
BRUCK SYNDROME 2	0.00301205	4.790647259459662
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00301205	4.790647259459662
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00301205	4.790647259459662
AUTOSOMAL DOMINANT CUTIS LAXA	0.00301205	4.790647259459662
RUVALCABA SYNDROME	0.00301205	4.790647259459662
LOWRY-MACLEAN SYNDROME	0.00301205	4.790647259459662
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.00301205	4.790647259459662
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00301205	4.790647259459662
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00301205	4.790647259459662
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00301205	4.790647259459662
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00301205	4.790647259459662
ISOTRETINOIN-LIKE SYNDROME	0.00301205	4.790647259459662
EHLERS-DANLOS SYNDROME, TYPE I	0.00301205	4.790647259459662
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00301205	4.790647259459662
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00301205	4.790647259459662
HUNTER-MACDONALD SYNDROME	0.00301205	4.790647259459662
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00301205	4.790647259459662
PERSISTENT MÜLLERIAN DUCT SYNDROME	0.00301205	4.790647259459662
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00301205	4.790647259459662
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.00301205	4.790647259459662
LOEYS-DIETZ SYNDROME 5	0.00301205	4.790647259459662
DISTAL MONOSOMY 3P	0.00301205	4.790647259459662
POLYDACTYLY-MYOPIA SYNDROME	0.00301205	4.790647259459662
OMPHALOCELE, AUTOSOMAL	0.00301205	4.790647259459662
MORQUIO SYNDROME A	0.00301205	4.790647259459662
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00301205	4.790647259459662
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.00301205	4.790647259459662
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00301205	4.790647259459662
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00301205	4.790647259459662
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00301205	4.790647259459662
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00301205	4.790647259459662
HAMAMY SYNDROME; HMMS	0.00301205	4.790647259459662
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00301205	4.790647259459662
SHORT SYNDROME	0.00301205	4.790647259459662
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00301205	4.790647259459662
FAMILIAL ARTICULAR HYPERMOBILITY SYNDROME	0.00301205	4.790647259459662
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.002450314	3.897209557914258
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.002450314	3.897209557914258
SAUL-WILSON SYNDROME; SWILS	0.002450314	3.897209557914258
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.002450314	3.897209557914258
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.002450314	3.897209557914258
11P15.4 MICRODUPLICATION SYNDROME	0.002450314	3.897209557914258
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.002450314	3.897209557914258
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.002450314	3.897209557914258
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.002450314	3.897209557914258
DESBUQUOIS DYSPLASIA 2; DBQD2	0.002450314	3.897209557914258
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.002450314	3.897209557914258
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.002450314	3.897209557914258
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.002450314	3.897209557914258
PRADER-WILLI SYNDROME; PWS	0.002450314	3.897209557914258
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.002450314	3.897209557914258
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.002450314	3.897209557914258
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.002450314	3.897209557914258
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002450314	3.897209557914258
XQ25 DUPLICATION SYNDROME	0.002450314	3.897209557914258
SMITH-MAGENIS SYNDROME; SMS	0.002450314	3.897209557914258
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.002450314	3.897209557914258
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.002450314	3.897209557914258
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.002450314	3.897209557914258
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.002450314	3.897209557914258
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.002450314	3.897209557914258
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.002450314	3.897209557914258
COFFIN-SIRIS SYNDROME 6; CSS6	0.002450314	3.897209557914258
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.002450314	3.897209557914258
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.002450314	3.897209557914258
HAREL-YOON SYNDROME; HAYOS	0.002450314	3.897209557914258
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.002450314	3.897209557914258
GENITOPATELLAR SYNDROME	0.002450314	3.897209557914258
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.002450314	3.897209557914258
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.002450314	3.897209557914258
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.002450314	3.897209557914258
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.002450314	3.897209557914258
AL KAISSI SYNDROME; ALKAS	0.002450314	3.897209557914258
PMM2-CDG	0.002450314	3.897209557914258
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.002450314	3.897209557914258
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.002450314	3.897209557914258
ABLEPHARON MACROSTOMIA SYNDROME	0.002450314	3.897209557914258
7P22.1 MICRODUPLICATION SYNDROME	0.002450314	3.897209557914258
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.002450314	3.897209557914258
COHEN-GIBSON SYNDROME; COGIS	0.002450314	3.897209557914258
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.002450314	3.897209557914258
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.002450314	3.897209557914258
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.002450314	3.897209557914258
JOUBERT SYNDROME 30; JBTS30	0.002450314	3.897209557914258
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002450314	3.897209557914258
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.002450314	3.897209557914258
CHROMOSOME 5Q12 DELETION SYNDROME	0.002450314	3.897209557914258
SHASHI-PENA SYNDROME; SHAPNS	0.002450314	3.897209557914258
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.002450314	3.897209557914258
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.002450314	3.897209557914258
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.002450314	3.897209557914258
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.002450314	3.897209557914258
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.002450314	3.897209557914258
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.002450314	3.897209557914258
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.002450314	3.897209557914258
LIG4 SYNDROME	0.002450314	3.897209557914258
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.002450314	3.897209557914258
22Q11.2 MICRODUPLICATION SYNDROME	0.002450314	3.897209557914258
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.002450314	3.897209557914258
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.002450314	3.897209557914258
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.002450314	3.897209557914258
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.002450314	3.897209557914258
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.002450314	3.897209557914258
17Q11.2 MICRODUPLICATION SYNDROME	0.002450314	3.897209557914258
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.002450314	3.897209557914258
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.002450314	3.897209557914258
PELIZAEUS-MERZBACHER DISEASE	0.002450314	3.897209557914258
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.002450314	3.897209557914258
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.002450314	3.897209557914258
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.002450314	3.897209557914258
16P13.11 MICRODELETION SYNDROME	0.002450314	3.897209557914258
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.002450314	3.897209557914258
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.002450314	3.897209557914258
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.002450314	3.897209557914258
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.002450314	3.897209557914258
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002450314	3.897209557914258
SAY-BARBER-MILLER SYNDROME	0.002450314	3.897209557914258
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.002450314	3.897209557914258
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.002450314	3.897209557914258
3Q29 MICRODELETION SYNDROME	0.002450314	3.897209557914258
15Q11Q13 MICRODUPLICATION SYNDROME	0.002450314	3.897209557914258
12Q14 MICRODELETION SYNDROME	0.002450314	3.897209557914258
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.002450314	3.897209557914258
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.002450314	3.897209557914258
8P23.1 DUPLICATION SYNDROME	0.002450314	3.897209557914258
DUCHENNE MUSCULAR DYSTROPHY	0.002450314	3.897209557914258
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.002450314	3.897209557914258
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.002450314	3.897209557914258
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.002450314	3.897209557914258
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.002450314	3.897209557914258
MENTAL RETARDATION, X-LINKED 9	0.002450314	3.897209557914258
EPILEPSY, PYRIDOXINE-DEPENDENT	0.002450314	3.897209557914258
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.002450314	3.897209557914258
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.002450314	3.897209557914258
SPINOCEREBELLAR ATAXIA TYPE 29	0.002450314	3.897209557914258
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.002450314	3.897209557914258
DISTAL MONOSOMY 12Q	0.002450314	3.897209557914258
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.002450314	3.897209557914258
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.002450314	3.897209557914258
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.002450314	3.897209557914258
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.002450314	3.897209557914258
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.002450314	3.897209557914258
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.002450314	3.897209557914258
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.002450314	3.897209557914258
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.002450314	3.897209557914258
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.002450314	3.897209557914258
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.002450314	3.897209557914258
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.002450314	3.897209557914258
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.002450314	3.897209557914258
OKAMOTO SYNDROME	0.002450314	3.897209557914258
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.002450314	3.897209557914258
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.002450314	3.897209557914258
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.002450314	3.897209557914258
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.002450314	3.897209557914258
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.002450314	3.897209557914258
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.002450314	3.897209557914258
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.002450314	3.897209557914258
WIEACKER-WOLFF SYNDROME	0.002450314	3.897209557914258
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.002450314	3.897209557914258
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.002450314	3.897209557914258
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.002450314	3.897209557914258
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.002450314	3.897209557914258
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.002450314	3.897209557914258
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.002450314	3.897209557914258
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.002450314	3.897209557914258
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.002450314	3.897209557914258
NOONAN SYNDROME 6; NS6	0.002450314	3.897209557914258
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.002450314	3.897209557914258
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.002450314	3.897209557914258
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.002450314	3.897209557914258
FORSYTHE-WAKELING SYNDROME; FWS	0.002450314	3.897209557914258
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.002450314	3.897209557914258
GALACTOSE EPIMERASE DEFICIENCY	0.002450314	3.897209557914258
EPIDERMAL NEVUS SYNDROME	0.002450314	3.897209557914258
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.002450314	3.897209557914258
BILATERAL POLYMICROGYRIA	0.002450314	3.897209557914258
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.002450314	3.897209557914258
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.002450314	3.897209557914258
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.002450314	3.897209557914258
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.002450314	3.897209557914258
SALLA DISEASE	0.002450314	3.897209557914258
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.00190476	3.029509229238686
DISTAL TRISOMY 5Q	0.00190476	3.029509229238686
49,XYYYY SYNDROME	0.00190476	3.029509229238686
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	3.029509229238686
TENORIO SYNDROME; TNORS	0.00190476	3.029509229238686
RETINITIS PIGMENTOSA 71; RP71	0.00190476	3.029509229238686
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.00190476	3.029509229238686
8P INVERTED DUPLICATION/DELETION SYNDROME	0.00190476	3.029509229238686
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00190476	3.029509229238686
MILD CANAVAN DISEASE	0.00190476	3.029509229238686
SPINOCEREBELLAR ATAXIA TYPE 3	0.00190476	3.029509229238686
PARTINGTON SYNDROME	0.00190476	3.029509229238686
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00190476	3.029509229238686
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.00190476	3.029509229238686
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00190476	3.029509229238686
BRACHYDACTYLY, TYPE A1, D	0.00190476	3.029509229238686
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.00190476	3.029509229238686
CHITAYAT SYNDROME	0.00190476	3.029509229238686
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00190476	3.029509229238686
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00190476	3.029509229238686
20P13 MICRODELETION SYNDROME	0.00190476	3.029509229238686
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00190476	3.029509229238686
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00190476	3.029509229238686
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	3.029509229238686
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.00190476	3.029509229238686
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.00190476	3.029509229238686
TEMPLE SYNDROME	0.00190476	3.029509229238686
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00190476	3.029509229238686
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.00190476	3.029509229238686
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00190476	3.029509229238686
ACERULOPLASMINEMIA	0.00190476	3.029509229238686
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.00190476	3.029509229238686
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00190476	3.029509229238686
UNILATERAL POLYMICROGYRIA	0.00190476	3.029509229238686
HUNTINGTON DISEASE-LIKE 1	0.00190476	3.029509229238686
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00190476	3.029509229238686
17Q12 MICRODUPLICATION SYNDROME	0.00190476	3.029509229238686
LARYNGOTRACHEAL ANGIOMA	0.00190476	3.029509229238686
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00190476	3.029509229238686
17Q24.2 MICRODELETION SYNDROME	0.00190476	3.029509229238686
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00190476	3.029509229238686
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00190476	3.029509229238686
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00190476	3.029509229238686
FAMILIAL MULTIPLE LIPOMATOSIS	0.00190476	3.029509229238686
CLEFT LIP/PALATE	0.00190476	3.029509229238686
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.00190476	3.029509229238686
3Q27.3 MICRODELETION SYNDROME	0.00190476	3.029509229238686
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.00190476	3.029509229238686
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.00190476	3.029509229238686
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00190476	3.029509229238686
2Q23.1 MICRODELETION SYNDROME	0.00190476	3.029509229238686
13Q12.3 MICRODELETION SYNDROME	0.00190476	3.029509229238686
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	3.029509229238686
CENTRAL CONGENITAL HYPOTHYROIDISM	0.00190476	3.029509229238686
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00190476	3.029509229238686
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.00190476	3.029509229238686
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00190476	3.029509229238686
NAGER SYNDROME	0.00190476	3.029509229238686
19Q13.11 MICRODELETION SYNDROME	0.00190476	3.029509229238686
MASA SYNDROME	0.00190476	3.029509229238686
EPISODIC ATAXIA TYPE 1	0.00190476	3.029509229238686
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00190476	3.029509229238686
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.00190476	3.029509229238686
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00190476	3.029509229238686
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00190476	3.029509229238686
BARDET-BIEDL SYNDROME 21; BBS21	0.00190476	3.029509229238686
TEMPLE SYNDROME	0.00190476	3.029509229238686
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.00190476	3.029509229238686
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00190476	3.029509229238686
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00190476	3.029509229238686
OROFACIODIGITAL SYNDROME XVII	0.00190476	3.029509229238686
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00190476	3.029509229238686
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00190476	3.029509229238686
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00190476	3.029509229238686
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00190476	3.029509229238686
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00190476	3.029509229238686
PROGRESSIVE SUPRANUCLEAR PALSY	0.00190476	3.029509229238686
MICROTIA	0.00190476	3.029509229238686
WIEDEMANN-STEINER SYNDROME	0.00190476	3.029509229238686
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00190476	3.029509229238686
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00190476	3.029509229238686
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00190476	3.029509229238686
MICROTRIPLICATION 11Q24.1	0.00190476	3.029509229238686
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00190476	3.029509229238686
CRANIOSYNOSTOSIS 7	0.00190476	3.029509229238686
VERVERI-BRADY SYNDROME; VERBRAS	0.00190476	3.029509229238686
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00190476	3.029509229238686
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	3.029509229238686
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00190476	3.029509229238686
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00190476	3.029509229238686
MACHADO-JOSEPH DISEASE TYPE 1	0.00190476	3.029509229238686
MACHADO-JOSEPH DISEASE TYPE 2	0.00190476	3.029509229238686
MACHADO-JOSEPH DISEASE TYPE 3	0.00190476	3.029509229238686
COFFIN-SIRIS SYNDROME 8; CSS8	0.00190476	3.029509229238686
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.00190476	3.029509229238686
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.00190476	3.029509229238686
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	3.029509229238686
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00190476	3.029509229238686
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00190476	3.029509229238686
POSTORGASMIC ILLNESS SYNDROME	0.00190476	3.029509229238686
ALG13-CDG	0.00190476	3.029509229238686
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00190476	3.029509229238686
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00190476	3.029509229238686
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00190476	3.029509229238686
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	3.029509229238686
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00190476	3.029509229238686
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	3.029509229238686
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	3.029509229238686
MENTAL RETARDATION, X-LINKED 93	0.00190476	3.029509229238686
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00190476	3.029509229238686
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00190476	3.029509229238686
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00190476	3.029509229238686
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	3.029509229238686
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00190476	3.029509229238686
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.00190476	3.029509229238686
224550 DYSTONIA WITH RINGBINDEN	0.00190476	3.029509229238686
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	3.029509229238686
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	3.029509229238686
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00190476	3.029509229238686
HYPERLYSINEMIA, TYPE I	0.00190476	3.029509229238686
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.00190476	3.029509229238686
MENTAL RETARDATION, X-LINKED 95	0.00190476	3.029509229238686
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00190476	3.029509229238686
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.00190476	3.029509229238686
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00190476	3.029509229238686
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	3.029509229238686
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00190476	3.029509229238686
HYPOGLOSSIA WITH SITUS INVERSUS	0.00190476	3.029509229238686
FG SYNDROME 2; FGS2	0.00190476	3.029509229238686
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	3.029509229238686
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00190476	3.029509229238686
CHROMOSOME 13Q14 DELETION SYNDROME	0.00190476	3.029509229238686
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	3.029509229238686
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.00190476	3.029509229238686
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00190476	3.029509229238686
MEIER-GORLIN SYNDROME 3; MGORS3	0.00190476	3.029509229238686
KLEEFSTRA SYNDROME	0.00190476	3.029509229238686
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00190476	3.029509229238686
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00190476	3.029509229238686
MENTAL RETARDATION, X-LINKED 19	0.00190476	3.029509229238686
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00190476	3.029509229238686
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.00190476	3.029509229238686
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00190476	3.029509229238686
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00190476	3.029509229238686
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00190476	3.029509229238686
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00190476	3.029509229238686
7Q11.23 DUPLICATION SYNDROME	0.00190476	3.029509229238686
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00190476	3.029509229238686
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	3.029509229238686
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00190476	3.029509229238686
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00190476	3.029509229238686
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00190476	3.029509229238686
DYSTONIA 16; DYT16	0.00190476	3.029509229238686
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00190476	3.029509229238686
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.00190476	3.029509229238686
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00190476	3.029509229238686
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00190476	3.029509229238686
MAXILLOFACIAL DYSOSTOSIS	0.00190476	3.029509229238686
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.00190476	3.029509229238686
AUTISM	0.00190476	3.029509229238686
MOEBIUS SYNDROME; MBS	0.00190476	3.029509229238686
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00190476	3.029509229238686
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00190476	3.029509229238686
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00190476	3.029509229238686
SPEECH-LANGUAGE DISORDER 1	0.00190476	3.029509229238686
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00190476	3.029509229238686
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00190476	3.029509229238686
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.00190476	3.029509229238686
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.00190476	3.029509229238686
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00190476	3.029509229238686
ABLEPHARON-MACROSTOMIA SYNDROME	0.00190476	3.029509229238686
CHROMOSOME 17Q12 DELETION SYNDROME	0.00190476	3.029509229238686
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00190476	3.029509229238686
ASPARTYLGLUCOSAMINURIA; AGU	0.00190476	3.029509229238686
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00190476	3.029509229238686
MONOSOMY 18Q	0.001790884	2.848390141800487
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001790884	2.848390141800487
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001790884	2.848390141800487
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.001790884	2.848390141800487
DISTAL TRISOMY 6P	0.001790884	2.848390141800487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001790884	2.848390141800487
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.001790884	2.848390141800487
FETAL HYDANTOIN SYNDROME	0.001790884	2.848390141800487
MIETENS SYNDROME	0.001790884	2.848390141800487
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001790884	2.848390141800487
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001790884	2.848390141800487
1Q21.1 MICRODUPLICATION SYNDROME	0.001790884	2.848390141800487
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.001790884	2.848390141800487
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001790884	2.848390141800487
KBG SYNDROME	0.001790884	2.848390141800487
DUANE RETRACTION SYNDROME	0.001790884	2.848390141800487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001790884	2.848390141800487
MATERNAL PHENYLKETONURIA	0.001790884	2.848390141800487
JOUBERT SYNDROME WITH RENAL DEFECT	0.001790884	2.848390141800487
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001790884	2.848390141800487
HARTNUP DISEASE	0.001790884	2.848390141800487
OPTIC PATHWAY GLIOMA	0.001790884	2.848390141800487
GERMAN SYNDROME	0.001790884	2.848390141800487
FLOATING-HARBOR SYNDROME	0.001790884	2.848390141800487
COHEN SYNDROME	0.001790884	2.848390141800487
TOLUENE EMBRYOPATHY	0.001790884	2.848390141800487
FETAL TRIMETHADIONE SYNDROME	0.001790884	2.848390141800487
SCHINDLER DISEASE, TYPE I	0.001790884	2.848390141800487
CONGENITAL DISORDER OF GLYCOSYLATION	0.001790884	2.848390141800487
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001790884	2.848390141800487
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001790884	2.848390141800487
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.001790884	2.848390141800487
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001790884	2.848390141800487
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001790884	2.848390141800487
BAKER-GORDON SYNDROME; BAGOS	0.001790884	2.848390141800487
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.001790884	2.848390141800487
JOUBERT SYNDROME 14	0.001790884	2.848390141800487
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001790884	2.848390141800487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.001790884	2.848390141800487
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001790884	2.848390141800487
PONTINE TEGMENTAL CAP DYSPLASIA	0.001790884	2.848390141800487
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001790884	2.848390141800487
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.001790884	2.848390141800487
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.001790884	2.848390141800487
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001790884	2.848390141800487
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001790884	2.848390141800487
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001790884	2.848390141800487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001790884	2.848390141800487
JOUBERT SYNDROME 31; JBTS31	0.001790884	2.848390141800487
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.001790884	2.848390141800487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001790884	2.848390141800487
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001790884	2.848390141800487
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001790884	2.848390141800487
COFFIN-SIRIS SYNDROME	0.001790884	2.848390141800487
PENTASOMY X	0.001790884	2.848390141800487
CODAS SYNDROME	0.001790884	2.848390141800487
XQ21 MICRODELETION SYNDROME	0.001790884	2.848390141800487
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.001790884	2.848390141800487
CHARGE SYNDROME	0.001790884	2.848390141800487
HADZISELIMOVIC SYNDROME	0.001790884	2.848390141800487
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001790884	2.848390141800487
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.001790884	2.848390141800487
MONOSOMY 9P	0.001790884	2.848390141800487
CARDIOFACIOCUTANEOUS SYNDROME	0.001790884	2.848390141800487
NEPHRONOPHTHISIS 11; NPHP11	0.001790884	2.848390141800487
ADAMS-OLIVER SYNDROME 2; AOS2	0.001790884	2.848390141800487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001790884	2.848390141800487
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001790884	2.848390141800487
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.001790884	2.848390141800487
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.001790884	2.848390141800487
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001790884	2.848390141800487
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001790884	2.848390141800487
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001790884	2.848390141800487
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.001790884	2.848390141800487
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001790884	2.848390141800487
ISOLATED COMPLEX I DEFICIENCY	0.001790884	2.848390141800487
HYPERTRYPTOPHANEMIA; HYPTRP	0.001790884	2.848390141800487
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001790884	2.848390141800487
MUCOLIPIDOSIS IV; ML4	0.001790884	2.848390141800487
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001790884	2.848390141800487
RICHARDS-RUNDLE SYNDROME; RRNS	0.001790884	2.848390141800487
MARINESCO-SJOGREN SYNDROME; MSS	0.001790884	2.848390141800487
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001790884	2.848390141800487
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001790884	2.848390141800487
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.001790884	2.848390141800487
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.001790884	2.848390141800487
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.001790884	2.848390141800487
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001790884	2.848390141800487
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.001790884	2.848390141800487
JOUBERT SYNDROME	0.001790884	2.848390141800487
GAUCHER DISEASE, TYPE II	0.001790884	2.848390141800487
LEIGH SYNDROME; LS	0.001790884	2.848390141800487
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001790884	2.848390141800487
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.001790884	2.848390141800487
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.001790884	2.848390141800487
CHAR SYNDROME	0.001790884	2.848390141800487
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001790884	2.848390141800487
INCONTINENTIA PIGMENTI	0.001790884	2.848390141800487
OROFACIODIGITAL SYNDROME IX; OFD9	0.001790884	2.848390141800487
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001790884	2.848390141800487
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.001790884	2.848390141800487
MARINESCO-SJÖGREN SYNDROME	0.001790884	2.848390141800487
COSTELLO SYNDROME; CSTLO	0.001790884	2.848390141800487
FRONTOOCULAR SYNDROME	0.001790884	2.848390141800487
CHAR SYNDROME	0.001790884	2.848390141800487
POTOCKI-SHAFFER SYNDROME	0.001790884	2.848390141800487
15Q13.3 MICRODELETION SYNDROME	0.001790884	2.848390141800487
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.001790884	2.848390141800487
ANGELMAN SYNDROME	0.001790884	2.848390141800487
X SMALL RINGS	0.001790884	2.848390141800487
KOOLEN-DE VRIES SYNDROME	0.001790884	2.848390141800487
KABUKI SYNDROME 1	0.001790884	2.848390141800487
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001790884	2.848390141800487
TETRASOMY X	0.001790884	2.848390141800487
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.001790884	2.848390141800487
TREACHER-COLLINS SYNDROME	0.001790884	2.848390141800487
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001790884	2.848390141800487
PELGER-HUET ANOMALY; PHA	0.001790884	2.848390141800487
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001790884	2.848390141800487
FANCONI ANEMIA	0.001790884	2.848390141800487
SCHIZENCEPHALY	0.001790884	2.848390141800487
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001790884	2.848390141800487
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001790884	2.848390141800487
RUBINSTEIN-TAYBI SYNDROME	0.001790884	2.848390141800487
MONOSOMY 9Q22.3	0.001790884	2.848390141800487
C SYNDROME	0.001790884	2.848390141800487
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001790884	2.848390141800487
3MC SYNDROME 2	0.001790884	2.848390141800487
ROTHMUND-THOMSON SYNDROME	0.001790884	2.848390141800487
PHACE SYNDROME	0.001790884	2.848390141800487
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001790884	2.848390141800487
PYRIDOXINE-DEPENDENT EPILEPSY	0.001790884	2.848390141800487
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.001790884	2.848390141800487
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.001790884	2.848390141800487
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.001790884	2.848390141800487
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.001790884	2.848390141800487
OCULOECTODERMAL SYNDROME; OES	0.001790884	2.848390141800487
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.001790884	2.848390141800487
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001790884	2.848390141800487
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.001790884	2.848390141800487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001790884	2.848390141800487
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.001790884	2.848390141800487
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001790884	2.848390141800487
ALG11-CDG	0.001790884	2.848390141800487
WOLF-HIRSCHHORN SYNDROME	0.001790884	2.848390141800487
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.001790884	2.848390141800487
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001790884	2.848390141800487
MUENKE SYNDROME	0.001790884	2.848390141800487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001790884	2.848390141800487
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.001790884	2.848390141800487
BOHRING-OPITZ SYNDROME	0.001790884	2.848390141800487
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.001790884	2.848390141800487
TRISOMY 17P	0.001790884	2.848390141800487
GLYCEROL KINASE DEFICIENCY; GKD	0.001790884	2.848390141800487
SARCOSINEMIA	0.001790884	2.848390141800487
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.001790884	2.848390141800487
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.001790884	2.848390141800487
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001790884	2.848390141800487
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001790884	2.848390141800487
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.001790884	2.848390141800487
SSR4-CDG	0.001790884	2.848390141800487
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001790884	2.848390141800487
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001790884	2.848390141800487
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001790884	2.848390141800487
OROFACIODIGITAL SYNDROME VIII; OFD8	0.001790884	2.848390141800487
19P13.13 MICRODELETION SYNDROME	0.001790884	2.848390141800487
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001790884	2.848390141800487
ISOLATED PLAGIOCEPHALY	0.001790884	2.848390141800487
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.001790884	2.848390141800487
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001790884	2.848390141800487
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.001790884	2.848390141800487
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.001790884	2.848390141800487
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001790884	2.848390141800487
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001790884	2.848390141800487
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001790884	2.848390141800487
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.001790884	2.848390141800487
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001790884	2.848390141800487
2Q23.1 MICRODUPLICATION SYNDROME	0.001790884	2.848390141800487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.001790884	2.848390141800487
8P23.1 MICRODELETION SYNDROME	0.001790884	2.848390141800487
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001790884	2.848390141800487
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001790884	2.848390141800487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001790884	2.848390141800487
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001790884	2.848390141800487
RAHMAN SYNDROME	0.001790884	2.848390141800487
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.001790884	2.848390141800487
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001790884	2.848390141800487
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001790884	2.848390141800487
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.001790884	2.848390141800487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001790884	2.848390141800487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001790884	2.848390141800487
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001790884	2.848390141800487
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001790884	2.848390141800487
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.001790884	2.848390141800487
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001790884	2.848390141800487
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001790884	2.848390141800487
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001790884	2.848390141800487
OPTIC ATROPHY 11; OPA11	0.001790884	2.848390141800487
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001790884	2.848390141800487
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.001790884	2.848390141800487
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001790884	2.848390141800487
MEIER-GORLIN SYNDROME 7	0.001790884	2.848390141800487
JOUBERT SYNDROME 21	0.001790884	2.848390141800487
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001790884	2.848390141800487
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001790884	2.848390141800487
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.001790884	2.848390141800487
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.001790884	2.848390141800487
CRANIOSYNOSTOSIS 6; CRS6	0.001790884	2.848390141800487
SENIOR-LOKEN SYNDROME 9	0.001790884	2.848390141800487
ZTTK SYNDROME; ZTTKS	0.001790884	2.848390141800487
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001790884	2.848390141800487
THAUVIN-ROBINET-FAIVRE SYNDROME	0.001790884	2.848390141800487
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00124533	1.980689813124915
PETERS ANOMALY	0.00124533	1.980689813124915
NON-DISTAL MONOSOMY 10Q	0.00124533	1.980689813124915
DISTAL MONOSOMY 10P	0.00124533	1.980689813124915
NOONAN SYNDROME	0.00124533	1.980689813124915
MEIER-GORLIN SYNDROME 1; MGORS1	0.00124533	1.980689813124915
KNOBLOCH SYNDROME	0.00124533	1.980689813124915
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.00124533	1.980689813124915
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.00124533	1.980689813124915
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00124533	1.980689813124915
JACKSON-WEISS SYNDROME	0.00124533	1.980689813124915
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	1.980689813124915
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00124533	1.980689813124915
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00124533	1.980689813124915
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00124533	1.980689813124915
HYPERTELORISM, TEEBI TYPE	0.00124533	1.980689813124915
CRANIOFACIAL DYSSYNOSTOSIS	0.00124533	1.980689813124915
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00124533	1.980689813124915
PRIMARY CUTIS VERTICIS GYRATA	0.00124533	1.980689813124915
COOPER-JABS SYNDROME	0.00124533	1.980689813124915
FRONTORHINY	0.00124533	1.980689813124915
RENAL COLOBOMA SYNDROME	0.00124533	1.980689813124915
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00124533	1.980689813124915
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00124533	1.980689813124915
15Q26 OVERGROWTH SYNDROME	0.00124533	1.980689813124915
DISTAL MONOSOMY 7Q36	0.00124533	1.980689813124915
MUCOLIPIDOSIS TYPE IV	0.00124533	1.980689813124915
MOWAT-WILSON SYNDROME; MOWS	0.00124533	1.980689813124915
TRISOMY 4P	0.00124533	1.980689813124915
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00124533	1.980689813124915
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00124533	1.980689813124915
MARSHALL SYNDROME	0.00124533	1.980689813124915
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00124533	1.980689813124915
WOOLLY HAIR	0.00124533	1.980689813124915
HALLERMANN-STREIFF SYNDROME; HSS	0.00124533	1.980689813124915
MOEBIUS SYNDROME	0.00124533	1.980689813124915
GLUTATHIONURIA	0.00124533	1.980689813124915
21Q22.11Q22.12 MICRODELETION SYNDROME	0.00124533	1.980689813124915
ODONTOCHONDRODYSPLASIA	0.00124533	1.980689813124915
GAUCHER DISEASE, TYPE IIIC	0.00124533	1.980689813124915
CHANARIN-DORFMAN SYNDROME	0.00124533	1.980689813124915
MUSCLE-EYE-BRAIN DISEASE	0.00124533	1.980689813124915
MULTIMINICORE MYOPATHY	0.00124533	1.980689813124915
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.00124533	1.980689813124915
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.00124533	1.980689813124915
GAPO SYNDROME; GAPOS	0.00124533	1.980689813124915
FANCONI ANEMIA	0.00124533	1.980689813124915
COCKAYNE SYNDROME A; CSA	0.00124533	1.980689813124915
PETERS ANOMALY	0.00124533	1.980689813124915
OCULOCUTANEOUS ALBINISM	0.00124533	1.980689813124915
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00124533	1.980689813124915
BRANCHIOSKELETOGENITAL SYNDROME	0.00124533	1.980689813124915
BRANCHIO-OCULO-FACIAL SYNDROME	0.00124533	1.980689813124915
LAURENCE-MOON SYNDROME	0.00124533	1.980689813124915
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00124533	1.980689813124915
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00124533	1.980689813124915
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00124533	1.980689813124915
BENCZE SYNDROME	0.00124533	1.980689813124915
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.00124533	1.980689813124915
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00124533	1.980689813124915
GAUCHER DISEASE TYPE 2	0.00124533	1.980689813124915
GAUCHER DISEASE TYPE 3	0.00124533	1.980689813124915
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	1.980689813124915
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00124533	1.980689813124915
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00124533	1.980689813124915
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00124533	1.980689813124915
RETINOBLASTOMA	0.00124533	1.980689813124915
STEINERT MYOTONIC DYSTROPHY	0.00124533	1.980689813124915
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.00124533	1.980689813124915
SECKEL SYNDROME 1; SCKL1	0.00124533	1.980689813124915
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00124533	1.980689813124915
SPASTIC PARAPLEGIA 16, X-LINKED	0.00124533	1.980689813124915
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00124533	1.980689813124915
BUSCHKE-OLLENDORFF SYNDROME	0.00124533	1.980689813124915
C SYNDROME	0.00124533	1.980689813124915
CEREBROFACIOTHORACIC DYSPLASIA	0.00124533	1.980689813124915
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00124533	1.980689813124915
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00124533	1.980689813124915
OTOMANDIBULAR SYNDROME	0.00124533	1.980689813124915
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00124533	1.980689813124915
RENPENNING SYNDROME	0.00124533	1.980689813124915
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.00124533	1.980689813124915
GORLIN SYNDROME	0.00124533	1.980689813124915
MENTAL RETARDATION, X-LINKED 21	0.00124533	1.980689813124915
COATS DISEASE	0.00124533	1.980689813124915
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00124533	1.980689813124915
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00124533	1.980689813124915
MOSAIC MONOSOMY X	0.00124533	1.980689813124915
MONOSOMY X	0.00124533	1.980689813124915
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00124533	1.980689813124915
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00124533	1.980689813124915
OCULODENTODIGITAL DYSPLASIA	0.00124533	1.980689813124915
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00124533	1.980689813124915
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00124533	1.980689813124915
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00124533	1.980689813124915
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.00124533	1.980689813124915
CARTILAGE-HAIR HYPOPLASIA	0.00124533	1.980689813124915
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00124533	1.980689813124915
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.00124533	1.980689813124915
HALLERMANN-STREIFF SYNDROME	0.00124533	1.980689813124915
MCDONOUGH SYNDROME	0.00124533	1.980689813124915
PITT-HOPKINS-LIKE SYNDROME	0.00124533	1.980689813124915
WHITE FORELOCK WITH MALFORMATIONS	0.00124533	1.980689813124915
NEONATAL ADRENOLEUKODYSTROPHY	0.00124533	1.980689813124915
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	1.980689813124915
16P12.1P12.3 TRIPLICATION SYNDROME	0.00124533	1.980689813124915
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00124533	1.980689813124915
CONGENITAL HYDROCEPHALUS	0.00124533	1.980689813124915
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.00124533	1.980689813124915
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00124533	1.980689813124915
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.00124533	1.980689813124915
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00124533	1.980689813124915
DUANE-RADIAL RAY SYNDROME; DRRS	0.00124533	1.980689813124915
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	1.980689813124915
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00124533	1.980689813124915
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.00124533	1.980689813124915
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00124533	1.980689813124915
MOWAT-WILSON SYNDROME	0.00124533	1.980689813124915
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00124533	1.980689813124915
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00124533	1.980689813124915
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00124533	1.980689813124915
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00124533	1.980689813124915
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00124533	1.980689813124915
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00124533	1.980689813124915
GAUCHER DISEASE, PERINATAL LETHAL	0.00124533	1.980689813124915
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.00124533	1.980689813124915
SMITH-KINGSMORE SYNDROME; SKS	0.00124533	1.980689813124915
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00124533	1.980689813124915
SPINOCEREBELLAR ATAXIA TYPE 42	0.00124533	1.980689813124915
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00124533	1.980689813124915
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00124533	1.980689813124915
IVIC SYNDROME	0.00124533	1.980689813124915
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00124533	1.980689813124915
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.00124533	1.980689813124915
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00124533	1.980689813124915
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00124533	1.980689813124915
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00124533	1.980689813124915
HAND-FOOT-GENITAL SYNDROME	0.00124533	1.980689813124915
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00124533	1.980689813124915
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00124533	1.980689813124915
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00124533	1.980689813124915
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	1.980689813124915
SUMMITT SYNDROME	0.00124533	1.980689813124915
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.00124533	1.980689813124915
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.00124533	1.980689813124915
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00124533	1.980689813124915
6P22 MICRODELETION SYNDROME	0.00124533	1.980689813124915
X-LINKED RECESSIVE OCULAR ALBINISM	0.00124533	1.980689813124915
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00124533	1.980689813124915
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00124533	1.980689813124915
COFFIN-LOWRY SYNDROME	0.00124533	1.980689813124915
ALAGILLE SYNDROME	0.00124533	1.980689813124915
JOHANSON-BLIZZARD SYNDROME; JBS	0.00124533	1.980689813124915
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00124533	1.980689813124915
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00124533	1.980689813124915
FETAL IODINE SYNDROME	0.00124533	1.980689813124915
COCKAYNE SYNDROME	0.00124533	1.980689813124915
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00124533	1.980689813124915
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00124533	1.980689813124915
MOMO SYNDROME	0.00124533	1.980689813124915
EEM SYNDROME	0.00124533	1.980689813124915
HIDROTIC ECTODERMAL DYSPLASIA	0.00124533	1.980689813124915
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00124533	1.980689813124915
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00124533	1.980689813124915
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00124533	1.980689813124915
X-LINKED RETINAL DYSPLASIA	0.00124533	1.980689813124915
LINEAR VERRUCOUS NEVUS SYNDROME	0.00124533	1.980689813124915
PITT-HOPKINS SYNDROME	0.00124533	1.980689813124915
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00124533	1.980689813124915
DYSEQUILIBRIUM SYNDROME	0.00124533	1.980689813124915
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.00124533	1.980689813124915
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00124533	1.980689813124915
SPINOCEREBELLAR ATAXIA TYPE 34	0.00124533	1.980689813124915
FREEMAN-SHELDON SYNDROME	0.00124533	1.980689813124915
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	1.980689813124915
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	1.980689813124915
MCDONOUGH SYNDROME	0.00124533	1.980689813124915
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00124533	1.980689813124915
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00124533	1.980689813124915
CROUZON DISEASE	0.00124533	1.980689813124915
GASTROCUTANEOUS SYNDROME	0.00124533	1.980689813124915
LEIGH SYNDROME	0.00124533	1.980689813124915
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00124533	1.980689813124915
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.00124533	1.980689813124915
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00124533	1.980689813124915
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00124533	1.980689813124915
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	1.980689813124915
LAMBOTTE SYNDROME	0.00124533	1.980689813124915
BRANCHIOGENIC DEAFNESS SYNDROME	0.00124533	1.980689813124915
MALAN OVERGROWTH SYNDROME	0.00124533	1.980689813124915
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00124533	1.980689813124915
CORNELIA DE LANGE SYNDROME	0.00124533	1.980689813124915
RETINAL CONE DYSTROPHY 3B	0.00124533	1.980689813124915
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.00124533	1.980689813124915
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00124533	1.980689813124915
SENGERS SYNDROME	0.00124533	1.980689813124915
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.00124533	1.980689813124915
TETRASOMY 12P	0.00124533	1.980689813124915
WAARDENBURG SYNDROME TYPE 1	0.00124533	1.980689813124915
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00124533	1.980689813124915
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00124533	1.980689813124915
CONGENITAL RUBELLA SYNDROME	0.00124533	1.980689813124915
LERI PLEONOSTEOSIS	0.00124533	1.980689813124915
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00124533	1.980689813124915
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00124533	1.980689813124915
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00124533	1.980689813124915
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00124533	1.980689813124915
URBAN-ROGERS-MEYER SYNDROME	0.00124533	1.980689813124915
FRAGILE X SYNDROME	0.00124533	1.980689813124915
XERODERMA PIGMENTOSUM	0.00124533	1.980689813124915
CROSSED POLYSYNDACTYLY	0.00124533	1.980689813124915
AASE-SMITH SYNDROME	0.00124533	1.980689813124915
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00124533	1.980689813124915
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00124533	1.980689813124915
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00124533	1.980689813124915
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00124533	1.980689813124915
TURNER SYNDROME	0.00124533	1.980689813124915
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00124533	1.980689813124915
HEMIFACIAL MICROSOMIA	0.00124533	1.980689813124915
LEBER CONGENITAL AMAUROSIS 16	0.00124533	1.980689813124915
ROBINOW-SORAUF SYNDROME	0.00124533	1.980689813124915
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00124533	1.980689813124915
OCULAR ALBINISM	0.00124533	1.980689813124915
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	1.980689813124915
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00124533	1.980689813124915
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00124533	1.980689813124915
ELLIS VAN CREVELD SYNDROME	0.00124533	1.980689813124915
TOWNES-BROCKS SYNDROME	0.00124533	1.980689813124915
DESMOSTEROLOSIS	0.00124533	1.980689813124915
SPINOCEREBELLAR ATAXIA TYPE 27	0.00124533	1.980689813124915
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00124533	1.980689813124915
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00124533	1.980689813124915
CHIME SYNDROME	0.00124533	1.980689813124915
APERT SYNDROME	0.00124533	1.980689813124915
DOWN SYNDROME	0.00124533	1.980689813124915
OPTIC ATROPHY 1; OPA1	0.00124533	1.980689813124915
BASAL CELL NEVUS SYNDROME	0.00124533	1.980689813124915
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00124533	1.980689813124915
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00124533	1.980689813124915
PELVISCAPULAR DYSPLASIA	0.00124533	1.980689813124915
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.00124533	1.980689813124915
INCONTINENTIA PIGMENTI; IP	0.00124533	1.980689813124915
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00124533	1.980689813124915
CROUZON SYNDROME	0.00124533	1.980689813124915
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00124533	1.980689813124915
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00124533	1.980689813124915
ALAGILLE SYNDROME 1; ALGS1	0.00124533	1.980689813124915
MASA SYNDROME	0.00124533	1.980689813124915
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.00124533	1.980689813124915
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00124533	1.980689813124915
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00124533	1.980689813124915
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	1.980689813124915
15Q OVERGROWTH SYNDROME	0.00124533	1.980689813124915
BRANCHIOOCULOFACIAL SYNDROME	0.00124533	1.980689813124915
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	1.980689813124915
ADAMS-OLIVER SYNDROME	0.00124533	1.980689813124915
PROXIMAL SYMPHALANGISM	0.00124533	1.980689813124915
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00124533	1.980689813124915
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00124533	1.980689813124915
MELNICK-NEEDLES SYNDROME	0.00124533	1.980689813124915
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00124533	1.980689813124915
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00124533	1.980689813124915
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00124533	1.980689813124915
PROGEROID SYNDROME, PETTY TYPE	0.00124533	1.980689813124915
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00124533	1.980689813124915
CYCLIC VOMITING SYNDROME	0.00124533	1.980689813124915
JACOBSEN SYNDROME	0.00124533	1.980689813124915
IVIC SYNDROME	0.00124533	1.980689813124915
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00124533	1.980689813124915
RENPENNING SYNDROME 1; RENS1	0.00124533	1.980689813124915
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00124533	1.980689813124915
MENTAL RETARDATION, X-LINKED 1	0.00124533	1.980689813124915
ACRO-RENAL-OCULAR SYNDROME	0.00124533	1.980689813124915
MOSAIC TRISOMY 8	0.00124533	1.980689813124915
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00124533	1.980689813124915
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00124533	1.980689813124915
COSTELLO SYNDROME	0.00124533	1.980689813124915
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.00124533	1.980689813124915
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00124533	1.980689813124915
SPINOCEREBELLAR ATAXIA TYPE 25	0.00124533	1.980689813124915
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00124533	1.980689813124915
DIAMOND-BLACKFAN ANEMIA 1	0.00124533	1.980689813124915
ATAXIA-TELANGIECTASIA	0.00124533	1.980689813124915
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	1.980689813124915
SECKEL SYNDROME 5; SCKL5	0.00124533	1.980689813124915
STIFF SKIN SYNDROME	0.00124533	1.980689813124915
ABDUCENS PALSY	0.00124533	1.980689813124915
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00124533	1.980689813124915
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	1.980689813124915
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00124533	1.980689813124915
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00124533	1.980689813124915
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.00124533	1.980689813124915
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00124533	1.980689813124915
OCULOCUTANEOUS ALBINISM TYPE 2	0.00124533	1.980689813124915
HERMANSKY-PUDLAK SYNDROME	0.00124533	1.980689813124915
MORNING GLORY DISC ANOMALY	0.00124533	1.980689813124915
VITREORETINOCHOROIDOPATHY; VRCP	0.00124533	1.980689813124915
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	1.980689813124915
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00124533	1.980689813124915
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00124533	1.980689813124915
STICKLER SYNDROME	0.00124533	1.980689813124915
ANTLEY-BIXLER SYNDROME	0.00124533	1.980689813124915
SAETHRE-CHOTZEN SYNDROME	0.00124533	1.980689813124915
NOONAN SYNDROME 7; NS7	0.00124533	1.980689813124915
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00124533	1.980689813124915
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00124533	1.980689813124915
NANOPHTHALMOS	0.00124533	1.980689813124915
XP22.13P22.2 DUPLICATION SYNDROME	0.00124533	1.980689813124915
OCULOCUTANEOUS ALBINISM TYPE 4	0.00124533	1.980689813124915
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00124533	1.980689813124915
8Q21.11 MICRODELETION SYNDROME	0.00124533	1.980689813124915
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00124533	1.980689813124915
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.00124533	1.980689813124915
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00124533	1.980689813124915
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.00124533	1.980689813124915
CHRISTIANSON SYNDROME	0.00124533	1.980689813124915
GAUCHER DISEASE	0.00124533	1.980689813124915
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00124533	1.980689813124915
TRICHOTHIODYSTROPHY	0.000545554	0.8677003286755717
JOUBERT SYNDROME 24	0.000545554	0.8677003286755717
COG2-CDG	0.000545554	0.8677003286755717
FARBER DISEASE	0.000545554	0.8677003286755717
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000545554	0.8677003286755717
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.8677003286755717
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000545554	0.8677003286755717
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.8677003286755717
TETRASOMY 5P	0.000545554	0.8677003286755717
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.8677003286755717
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.8677003286755717
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.8677003286755717
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.8677003286755717
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.000545554	0.8677003286755717
ISOVALERIC ACIDEMIA	0.000545554	0.8677003286755717
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.8677003286755717
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.8677003286755717
SRD5A3-CDG	0.000545554	0.8677003286755717
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000545554	0.8677003286755717
REVESZ SYNDROME	0.000545554	0.8677003286755717
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.8677003286755717
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.8677003286755717
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.8677003286755717
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.8677003286755717
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.8677003286755717
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.8677003286755717
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.8677003286755717
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.8677003286755717
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.8677003286755717
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.000545554	0.8677003286755717
19P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.8677003286755717
FILIPPI SYNDROME	0.000545554	0.8677003286755717
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.8677003286755717
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000545554	0.8677003286755717
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.8677003286755717
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.8677003286755717
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.8677003286755717
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000545554	0.8677003286755717
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.8677003286755717
300270 ADRENOMYODYSTROPHY	0.000545554	0.8677003286755717
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.8677003286755717
PETERS-PLUS SYNDROME; PTRPLS	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.8677003286755717
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.8677003286755717
PELLAGRA-LIKE SYNDROME	0.000545554	0.8677003286755717
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.8677003286755717
BARDET-BIEDL SYNDROME 2	0.000545554	0.8677003286755717
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.000545554	0.8677003286755717
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.8677003286755717
CONGENITAL HYPOTHYROIDISM	0.000545554	0.8677003286755717
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.8677003286755717
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000545554	0.8677003286755717
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.8677003286755717
STT3B-CDG	0.000545554	0.8677003286755717
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000545554	0.8677003286755717
STT3A-CDG	0.000545554	0.8677003286755717
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000545554	0.8677003286755717
PYRUVATE CARBOXYLASE DEFICIENCY	0.000545554	0.8677003286755717
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.8677003286755717
DISTAL MONOSOMY 1Q	0.000545554	0.8677003286755717
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.8677003286755717
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000545554	0.8677003286755717
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.8677003286755717
ROIFMAN SYNDROME; RFMN	0.000545554	0.8677003286755717
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.8677003286755717
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.8677003286755717
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.8677003286755717
RIDDLE SYNDROME	0.000545554	0.8677003286755717
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.8677003286755717
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.8677003286755717
WAARDENBURG-SHAH SYNDROME	0.000545554	0.8677003286755717
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.8677003286755717
SLC35A2-CDG	0.000545554	0.8677003286755717
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.8677003286755717
PROPIONIC ACIDEMIA	0.000545554	0.8677003286755717
FUCOSIDOSIS	0.000545554	0.8677003286755717
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.8677003286755717
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.000545554	0.8677003286755717
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.8677003286755717
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.8677003286755717
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000545554	0.8677003286755717
JOUBERT SYNDROME 26	0.000545554	0.8677003286755717
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.8677003286755717
GRISCELLI SYNDROME	0.000545554	0.8677003286755717
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.8677003286755717
YUNIS-VARON SYNDROME	0.000545554	0.8677003286755717
WILSON-TURNER SYNDROME	0.000545554	0.8677003286755717
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.000545554	0.8677003286755717
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.8677003286755717
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.8677003286755717
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.000545554	0.8677003286755717
MEND SYNDROME; MEND	0.000545554	0.8677003286755717
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.000545554	0.8677003286755717
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.8677003286755717
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.000545554	0.8677003286755717
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.8677003286755717
MAN1B1-CDG	0.000545554	0.8677003286755717
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.8677003286755717
GALACTOSEMIA	0.000545554	0.8677003286755717
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.8677003286755717
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.8677003286755717
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.8677003286755717
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.8677003286755717
OROFACIODIGITAL SYNDROME VI	0.000545554	0.8677003286755717
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.000545554	0.8677003286755717
MEND SYNDROME	0.000545554	0.8677003286755717
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.8677003286755717
WEBB-DATTANI SYNDROME; WEDAS	0.000545554	0.8677003286755717
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.8677003286755717
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.8677003286755717
TRISOMY X	0.000545554	0.8677003286755717
DYSTONIA-APHONIA SYNDROME	0.000545554	0.8677003286755717
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.8677003286755717
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000545554	0.8677003286755717
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.8677003286755717
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000545554	0.8677003286755717
JOUBERT SYNDROME 25	0.000545554	0.8677003286755717
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.8677003286755717
DISTAL TRISOMY 17Q	0.000545554	0.8677003286755717
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.8677003286755717
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000545554	0.8677003286755717
INFANTILE SIALIC ACID STORAGE DISEASE	0.000545554	0.8677003286755717
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.8677003286755717
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.8677003286755717
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000545554	0.8677003286755717
SALT-AND-PEPPER SYNDROME	0.000545554	0.8677003286755717
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.000545554	0.8677003286755717
TRISOMY 18	0.000545554	0.8677003286755717
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.8677003286755717
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.8677003286755717
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.000545554	0.8677003286755717
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.8677003286755717
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.8677003286755717
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000545554	0.8677003286755717
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.000545554	0.8677003286755717
SULFOCYSTEINURIA	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.8677003286755717
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000545554	0.8677003286755717
EVEN-PLUS SYNDROME	0.000545554	0.8677003286755717
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.8677003286755717
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.8677003286755717
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.8677003286755717
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.000545554	0.8677003286755717
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.8677003286755717
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.8677003286755717
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.8677003286755717
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.8677003286755717
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.8677003286755717
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.000545554	0.8677003286755717
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.8677003286755717
SEPTOOPTIC DYSPLASIA	0.000545554	0.8677003286755717
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.8677003286755717
BRESEK SYNDROME	0.000545554	0.8677003286755717
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.8677003286755717
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000545554	0.8677003286755717
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.8677003286755717
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.8677003286755717
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.8677003286755717
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.8677003286755717
CURRARINO SYNDROME	0.000545554	0.8677003286755717
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.8677003286755717
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.8677003286755717
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.8677003286755717
CONGENITAL TOXOPLASMOSIS	0.000545554	0.8677003286755717
PEHO SYNDROME; PEHO	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000545554	0.8677003286755717
DPAGT1-CDG	0.000545554	0.8677003286755717
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.8677003286755717
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.8677003286755717
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.8677003286755717
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.8677003286755717
WALKER-WARBURG SYNDROME	0.000545554	0.8677003286755717
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.8677003286755717
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.8677003286755717
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.8677003286755717
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.000545554	0.8677003286755717
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.8677003286755717
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.8677003286755717
KEUTEL SYNDROME	0.000545554	0.8677003286755717
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.8677003286755717
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.8677003286755717
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.8677003286755717
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.8677003286755717
BIOTINIDASE DEFICIENCY	0.000545554	0.8677003286755717
CLASSIC PHENYLKETONURIA	0.000545554	0.8677003286755717
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000545554	0.8677003286755717
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000545554	0.8677003286755717
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.8677003286755717
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000545554	0.8677003286755717
AUSTRALIA ANTIGEN	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000545554	0.8677003286755717
ALG6-CDG	0.000545554	0.8677003286755717
ALG3-CDG	0.000545554	0.8677003286755717
ALG1-CDG	0.000545554	0.8677003286755717
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.000545554	0.8677003286755717
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.8677003286755717
ARGININOSUCCINIC ACIDURIA	0.000545554	0.8677003286755717
GRISCELLI SYNDROME TYPE 1	0.000545554	0.8677003286755717
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.8677003286755717
CHOPS SYNDROME; CHOPS	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.8677003286755717
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000545554	0.8677003286755717
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000545554	0.8677003286755717
FREE SIALIC ACID STORAGE DISEASE	0.000545554	0.8677003286755717
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000545554	0.8677003286755717
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.8677003286755717
TAY-SACHS DISEASE	0.000545554	0.8677003286755717
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.8677003286755717
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.8677003286755717
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.8677003286755717
MONOSOMY 13Q34	0.000545554	0.8677003286755717
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.8677003286755717
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.8677003286755717
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.8677003286755717
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000545554	0.8677003286755717
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.8677003286755717
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.8677003286755717
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.8677003286755717
ZEBRA BODY MYOPATHY	0.000545554	0.8677003286755717
RIGID SPINE SYNDROME	0.000545554	0.8677003286755717
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.8677003286755717
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.000545554	0.8677003286755717
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.8677003286755717
SPINOCEREBELLAR ATAXIA TYPE 13	0.000545554	0.8677003286755717
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.8677003286755717
ADAMS-OLIVER SYNDROME 1; AOS1	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.8677003286755717
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.8677003286755717
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.8677003286755717
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.8677003286755717
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.8677003286755717
XQ28 (MECP2) DUPLICATION	0.000545554	0.8677003286755717
MOSAIC TRISOMY 9	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.8677003286755717
LIG4 SYNDROME	0.000545554	0.8677003286755717
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.8677003286755717
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.8677003286755717
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.8677003286755717
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.000545554	0.8677003286755717
RECOMBINANT 8 SYNDROME	0.000545554	0.8677003286755717
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000545554	0.8677003286755717
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.8677003286755717
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.8677003286755717
PFEIFFER SYNDROME TYPE 2	0.000545554	0.8677003286755717
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.8677003286755717
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.8677003286755717
HURLER SYNDROME	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000545554	0.8677003286755717
KBG SYNDROME	0.000545554	0.8677003286755717
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.8677003286755717
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000545554	0.8677003286755717
HOLMES-GANG SYNDROME	0.000545554	0.8677003286755717
PALLISTER-HALL SYNDROME	0.000545554	0.8677003286755717
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.8677003286755717
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.8677003286755717
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.8677003286755717
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.8677003286755717
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.8677003286755717
THYROID ECTOPIA	0.000545554	0.8677003286755717
ATHYREOSIS	0.000545554	0.8677003286755717
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.8677003286755717
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.8677003286755717
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.8677003286755717
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.8677003286755717
THYROID HEMIAGENESIS	0.000545554	0.8677003286755717
THYROID HYPOPLASIA	0.000545554	0.8677003286755717
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.8677003286755717
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000545554	0.8677003286755717
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.8677003286755717
DISTAL MONOSOMY 19P13.3	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.000545554	0.8677003286755717
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000545554	0.8677003286755717
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.8677003286755717
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000545554	0.8677003286755717
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.8677003286755717
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000545554	0.8677003286755717
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.8677003286755717
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.8677003286755717
TRANSKETOLASE DEFICIENCY	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.8677003286755717
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000545554	0.8677003286755717
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.8677003286755717
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.000545554	0.8677003286755717
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.8677003286755717
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.8677003286755717
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.8677003286755717
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.8677003286755717
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.8677003286755717
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.8677003286755717
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.000545554	0.8677003286755717
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.8677003286755717
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000545554	0.8677003286755717
MACDERMOT-WINTER SYNDROME	0.000545554	0.8677003286755717
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.000545554	0.8677003286755717
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.000545554	0.8677003286755717
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.8677003286755717
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.8677003286755717
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.8677003286755717
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000545554	0.8677003286755717
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.8677003286755717
AICARDI-GOUTIÈRES SYNDROME	0.000545554	0.8677003286755717
KETOADIPICACIDURIA	0.000545554	0.8677003286755717
MAPLE SYRUP URINE DISEASE	0.000545554	0.8677003286755717
KRABBE DISEASE	0.000545554	0.8677003286755717
JAWAD SYNDROME	0.000545554	0.8677003286755717
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.8677003286755717
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.8677003286755717
RAINE SYNDROME	0.000545554	0.8677003286755717
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.000545554	0.8677003286755717
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.000545554	0.8677003286755717
OROTIC ACIDURIA	0.000545554	0.8677003286755717
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.8677003286755717
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.8677003286755717
LISSENCEPHALY 2; LIS2	0.000545554	0.8677003286755717
LATHOSTEROLOSIS	0.000545554	0.8677003286755717
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.8677003286755717
RING CHROMOSOME 14 SYNDROME	0.000545554	0.8677003286755717
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.8677003286755717
NAVAJO NEUROHEPATOPATHY	0.000545554	0.8677003286755717
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.8677003286755717
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.8677003286755717
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.000545554	0.8677003286755717
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.8677003286755717
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.8677003286755717
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000545554	0.8677003286755717
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.8677003286755717
ELEJALDE DISEASE	0.000545554	0.8677003286755717
AU-KLINE SYNDROME; AUKS	0.000545554	0.8677003286755717
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.8677003286755717
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000545554	0.8677003286755717
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000545554	0.8677003286755717
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.8677003286755717
NOONAN SYNDROME 9; NS9	0.000545554	0.8677003286755717
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.8677003286755717
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.8677003286755717
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.8677003286755717
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.8677003286755717
ARIMA SYNDROME	0.000545554	0.8677003286755717
HYDROXYKYNURENINURIA	0.000545554	0.8677003286755717
CEDNIK SYNDROME	0.000545554	0.8677003286755717
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.8677003286755717
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000545554	0.8677003286755717
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.8677003286755717
TEMTAMY SYNDROME; TEMTYS	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.8677003286755717
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.8677003286755717
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000545554	0.8677003286755717
COACH SYNDROME	0.000545554	0.8677003286755717
CITRULLINEMIA, CLASSIC	0.000545554	0.8677003286755717
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.8677003286755717
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.8677003286755717
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.8677003286755717
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.8677003286755717
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.8677003286755717
JOUBERT SYNDROME 1	0.000545554	0.8677003286755717
WOLMAN DISEASE	0.000545554	0.8677003286755717
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.8677003286755717
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.8677003286755717
PYRUVATE DEHYDROGENASE DEFICIENCY	0.000545554	0.8677003286755717
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.8677003286755717
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000545554	0.8677003286755717
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.8677003286755717
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.8677003286755717
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.000545554	0.8677003286755717
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.8677003286755717
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.8677003286755717
AL-RAQAD SYNDROME; ARS	0.000545554	0.8677003286755717
LEBER CONGENITAL AMAUROSIS	0.000545554	0.8677003286755717
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000545554	0.8677003286755717
NIEMANN-PICK DISEASE TYPE C	0.000545554	0.8677003286755717
VICI SYNDROME; VICIS	0.000545554	0.8677003286755717
PEDIATRIC-ONSET GRAVES DISEASE	0.000545554	0.8677003286755717
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.8677003286755717
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000545554	0.8677003286755717
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.8677003286755717
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000545554	0.8677003286755717
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.8677003286755717
HYDROXYKYNURENINURIA	0.000545554	0.8677003286755717
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.8677003286755717
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000545554	0.8677003286755717
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.8677003286755717
WYBURN-MASON SYNDROME	0.000545554	0.8677003286755717
HOLOPROSENCEPHALY 1; HPE1	0.000545554	0.8677003286755717
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000545554	0.8677003286755717
HARTNUP DISORDER	0.000545554	0.8677003286755717
ATELOSTEOGENESIS TYPE III	0.000545554	0.8677003286755717
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.8677003286755717
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.8677003286755717
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000545554	0.8677003286755717
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.8677003286755717
MULTIPLE SULFATASE DEFICIENCY	0.000545554	0.8677003286755717
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.8677003286755717
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.8677003286755717
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.8677003286755717
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.8677003286755717
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000545554	0.8677003286755717
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.8677003286755717
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.8677003286755717
NARP SYNDROME	0.000545554	0.8677003286755717
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000545554	0.8677003286755717
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.8677003286755717
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.8677003286755717
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.8677003286755717
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.000545554	0.8677003286755717
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.8677003286755717
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.8677003286755717
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.8677003286755717
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.8677003286755717
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.8677003286755717
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000545554	0.8677003286755717
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.8677003286755717
TRANSALDOLASE DEFICIENCY	0.000545554	0.8677003286755717
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.8677003286755717
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.8677003286755717
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.8677003286755717
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.8677003286755717
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.8677003286755717
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.000545554	0.8677003286755717
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.8677003286755717
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000545554	0.8677003286755717
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.8677003286755717
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.8677003286755717
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.8677003286755717
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.8677003286755717
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.8677003286755717
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.8677003286755717
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.8677003286755717
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.8677003286755717
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000545554	0.8677003286755717
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.8677003286755717
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.8677003286755717
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.8677003286755717
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.8677003286755717
2Q37 MICRODELETION SYNDROME	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000545554	0.8677003286755717
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.8677003286755717
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.8677003286755717
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.8677003286755717
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000545554	0.8677003286755717
LISSENCEPHALY 4	0.000545554	0.8677003286755717
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000545554	0.8677003286755717
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.8677003286755717
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000545554	0.8677003286755717
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.8677003286755717
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.8677003286755717
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.8677003286755717
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000545554	0.8677003286755717
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.8677003286755717
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000545554	0.8677003286755717
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.8677003286755717
NOONAN SYNDROME 11; NS11	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.000545554	0.8677003286755717
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.8677003286755717
INFANTILE LIVER FAILURE SYNDROME 1	0.000545554	0.8677003286755717
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.8677003286755717
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000545554	0.8677003286755717
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000545554	0.8677003286755717
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.8677003286755717
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.000545554	0.8677003286755717
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000545554	0.8677003286755717
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000545554	0.8677003286755717
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.000545554	0.8677003286755717
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.8677003286755717
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.8677003286755717
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.8677003286755717
NOONAN SYNDROME 5; NS5	0.000545554	0.8677003286755717
DISTAL TRISOMY 18Q	0.000545554	0.8677003286755717
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.8677003286755717
MOSAIC TRISOMY 14	0.000545554	0.8677003286755717
TRISOMY 12P	0.000545554	0.8677003286755717
JOUBERT SYNDROME 7	0.000545554	0.8677003286755717
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.8677003286755717
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000545554	0.8677003286755717
CHÉDIAK-HIGASHI SYNDROME	0.000545554	0.8677003286755717
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.8677003286755717
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.8677003286755717
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000545554	0.8677003286755717
DISTAL MONOSOMY 9P	0.000545554	0.8677003286755717
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.8677003286755717
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000545554	0.8677003286755717
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.8677003286755717
TRISOMY 8Q	0.000545554	0.8677003286755717
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.8677003286755717
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.8677003286755717
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.8677003286755717
CORNELIA DE LANGE SYNDROME 3	0.000545554	0.8677003286755717
HOLOPROSENCEPHALY 7	0.000545554	0.8677003286755717
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.8677003286755717
POTOCKI-LUPSKI SYNDROME	0.000545554	0.8677003286755717
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000545554	0.8677003286755717
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.8677003286755717
TEMTAMY SYNDROME	0.000545554	0.8677003286755717
DYSKERATOSIS CONGENITA	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.8677003286755717
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.8677003286755717
LISSENCEPHALY 8; LIS8	0.000545554	0.8677003286755717
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000545554	0.8677003286755717
2P21 MICRODELETION SYNDROME	0.000545554	0.8677003286755717
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.8677003286755717
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000545554	0.8677003286755717
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.8677003286755717
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.8677003286755717
CINCA SYNDROME	0.000545554	0.8677003286755717
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000545554	0.8677003286755717
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.8677003286755717
RING CHROMOSOME 12 SYNDROME	0.000545554	0.8677003286755717
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.8677003286755717
CANAVAN DISEASE	0.000545554	0.8677003286755717
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.8677003286755717
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.8677003286755717
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.8677003286755717
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000545554	0.8677003286755717
AURICULOCONDYLAR SYNDROME	0.000545554	0.8677003286755717
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.8677003286755717
VICI SYNDROME	0.000545554	0.8677003286755717
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.8677003286755717
JOUBERT SYNDROME 8	0.000545554	0.8677003286755717
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.8677003286755717
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.000545554	0.8677003286755717
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.8677003286755717
SCHAAF-YANG SYNDROME; SHFYNG	0.000545554	0.8677003286755717
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.8677003286755717
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.8677003286755717
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.000545554	0.8677003286755717
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.8677003286755717
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000545554	0.8677003286755717
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000545554	0.8677003286755717
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.8677003286755717
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.8677003286755717
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000545554	0.8677003286755717
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.8677003286755717
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.8677003286755717
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.8677003286755717
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.8677003286755717
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000545554	0.8677003286755717
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.8677003286755717
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000545554	0.8677003286755717
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.8677003286755717
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000545554	0.8677003286755717
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000545554	0.8677003286755717
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000545554	0.8677003286755717
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.8677003286755717
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.8677003286755717
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.8677003286755717
CHROMOSOME 1P35 DELETION SYNDROME	0.000545554	0.8677003286755717
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.8677003286755717
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.8677003286755717
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.000545554	0.8677003286755717
JABERI-ELAHI SYNDROME; JABELS	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000545554	0.8677003286755717
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000545554	0.8677003286755717
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.8677003286755717
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.000545554	0.8677003286755717
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.8677003286755717
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000545554	0.8677003286755717
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000545554	0.8677003286755717
ALAZAMI SYNDROME; ALAZS	0.000545554	0.8677003286755717
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.8677003286755717
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.8677003286755717
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.8677003286755717
TYSHCHENKO SYNDROME	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000545554	0.8677003286755717
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.8677003286755717
STEEL SYNDROME; STLS	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.8677003286755717
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.8677003286755717
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000545554	0.8677003286755717
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.8677003286755717
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.8677003286755717
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.8677003286755717
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000545554	0.8677003286755717
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.000545554	0.8677003286755717
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.8677003286755717
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000545554	0.8677003286755717
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.8677003286755717
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.8677003286755717
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.8677003286755717
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.8677003286755717
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000545554	0.8677003286755717
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.000545554	0.8677003286755717
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.8677003286755717
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.8677003286755717
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.8677003286755717
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.8677003286755717
PEHO-LIKE SYNDROME; PEHOL	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.000545554	0.8677003286755717
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.8677003286755717
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.8677003286755717
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000545554	0.8677003286755717
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.8677003286755717
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000545554	0.8677003286755717
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000545554	0.8677003286755717
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000545554	0.8677003286755717
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.8677003286755717
HOLOPROSENCEPHALY 11	0.000545554	0.8677003286755717
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.8677003286755717
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.8677003286755717
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.8677003286755717
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.8677003286755717
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000545554	0.8677003286755717
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.8677003286755717
COFFIN-SIRIS SYNDROME 3; CSS3	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000545554	0.8677003286755717
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.8677003286755717
COFFIN-SIRIS SYNDROME 4; CSS4	0.000545554	0.8677003286755717
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.000545554	0.8677003286755717
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000545554	0.8677003286755717
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000545554	0.8677003286755717
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.8677003286755717
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.8677003286755717
MECKEL SYNDROME 13; MKS13	0.000545554	0.8677003286755717
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.8677003286755717
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.000545554	0.8677003286755717
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.8677003286755717
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.8677003286755717
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.8677003286755717
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.8677003286755717
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.8677003286755717
JOUBERT SYNDROME 15	0.000545554	0.8677003286755717
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.8677003286755717
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000545554	0.8677003286755717
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000545554	0.8677003286755717
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.8677003286755717
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000545554	0.8677003286755717
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.8677003286755717
JOUBERT SYNDROME 6	0.000545554	0.8677003286755717
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000545554	0.8677003286755717
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.000545554	0.8677003286755717
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000545554	0.8677003286755717
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000545554	0.8677003286755717
10Q22.3Q23.3 MICRODELETION SYNDROME	0.000545554	0.8677003286755717
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000545554	0.8677003286755717
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.8677003286755717
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.8677003286755717
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.8677003286755717
L1 SYNDROME	0.000545554	0.8677003286755717
OROFACIODIGITAL SYNDROME TYPE 6	0.000545554	0.8677003286755717
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.8677003286755717
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.8677003286755717
OPITZ G/BBB SYNDROME	0.000545554	0.8677003286755717
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.8677003286755717
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.000545554	0.8677003286755717
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.8677003286755717
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.8677003286755717
W SYNDROME	0.000545554	0.8677003286755717
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.8677003286755717
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.8677003286755717
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000545554	0.8677003286755717
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.8677003286755717
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000545554	0.8677003286755717
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.8677003286755717
SECKEL SYNDROME 8; SCKL8	0.000545554	0.8677003286755717
YOU-HOOVER-FONG SYNDROME; YHFS	0.000545554	0.8677003286755717
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.8677003286755717
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.8677003286755717
CURRY-JONES SYNDROME	0.000545554	0.8677003286755717
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.8677003286755717
OTOFACIOCERVICAL SYNDROME	0.000545554	0.8677003286755717
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.8677003286755717
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.8677003286755717
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.8677003286755717
CDAGS SYNDROME	0.000545554	0.8677003286755717
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.8677003286755717
XP21 MICRODELETION SYNDROME	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000545554	0.8677003286755717
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.8677003286755717
NOONAN SYNDROME 2; NS2	0.000545554	0.8677003286755717
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.8677003286755717
20P12.3 MICRODELETION SYNDROME	0.000545554	0.8677003286755717
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000545554	0.8677003286755717
MIRAGE SYNDROME; MIRAGE	0.000545554	0.8677003286755717
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.8677003286755717
17Q12 MICRODELETION SYNDROME	0.000545554	0.8677003286755717
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.8677003286755717
PROPIONIC ACIDEMIA	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000545554	0.8677003286755717
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000545554	0.8677003286755717
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.8677003286755717
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000545554	0.8677003286755717
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.8677003286755717
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000545554	0.8677003286755717
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000545554	0.8677003286755717
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.8677003286755717
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.8677003286755717
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.8677003286755717
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000545554	0.8677003286755717
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.8677003286755717
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.8677003286755717
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.8677003286755717
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.000545554	0.8677003286755717
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.000545554	0.8677003286755717
COG4-CDG	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.8677003286755717
PEHO SYNDROME	0.000545554	0.8677003286755717
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.8677003286755717
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.8677003286755717
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.8677003286755717
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000545554	0.8677003286755717
PETTIGREW SYNDROME	0.000545554	0.8677003286755717
CULLER-JONES SYNDROME; CJS	0.000545554	0.8677003286755717
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.000545554	0.8677003286755717
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.8677003286755717
ROBERTS SYNDROME	0.000545554	0.8677003286755717
OXOGLUTARIC ACIDURIA	0.000545554	0.8677003286755717
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000545554	0.8677003286755717
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.000545554	0.8677003286755717
WAISMAN SYNDROME; WSMN	0.000545554	0.8677003286755717
TARP SYNDROME; TARPS	0.000545554	0.8677003286755717
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.000545554	0.8677003286755717
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.000545554	0.8677003286755717
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.8677003286755717
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.8677003286755717
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.8677003286755717
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.8677003286755717
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.8677003286755717
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000545554	0.8677003286755717
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.8677003286755717
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.8677003286755717
SIALURIA	0.000545554	0.8677003286755717
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.000545554	0.8677003286755717
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.8677003286755717
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.8677003286755717
SENIOR-LOKEN SYNDROME	0.000545554	0.8677003286755717
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000545554	0.8677003286755717
SEVERE CANAVAN DISEASE	0.000545554	0.8677003286755717
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.8677003286755717
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.8677003286755717
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000545554	0.8677003286755717
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.8677003286755717
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.8677003286755717
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.8677003286755717
XIA-GIBBS SYNDROME	0.000545554	0.8677003286755717
BAND HETEROTOPIA; BH	0.000545554	0.8677003286755717
CODAS SYNDROME	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000545554	0.8677003286755717
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.8677003286755717
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.8677003286755717
TARP SYNDROME	0.000545554	0.8677003286755717
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.8677003286755717
CHROMOSOME 2Q37 DELETION SYNDROME	0.000545554	0.8677003286755717
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.8677003286755717
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.8677003286755717
HEART AND BRAIN MALFORMATION SYNDROME	0.000545554	0.8677003286755717
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.8677003286755717
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.8677003286755717
LOWRY-MACLEAN SYNDROME	0.000545554	0.8677003286755717
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.8677003286755717
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.8677003286755717
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.8677003286755717
HEREDITARY OROTIC ACIDURIA	0.000545554	0.8677003286755717
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.000545554	0.8677003286755717
AICARDI-GOUTIERES SYNDROME 7	0.000545554	0.8677003286755717
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.8677003286755717
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.8677003286755717
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.000545554	0.8677003286755717
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.8677003286755717
MEVALONIC ACIDURIA	0.000545554	0.8677003286755717
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000545554	0.8677003286755717
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.8677003286755717
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.8677003286755717
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000545554	0.8677003286755717
CONGENITAL VARICELLA SYNDROME	0.000545554	0.8677003286755717
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000545554	0.8677003286755717
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.8677003286755717
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.8677003286755717
FRIAS SYNDROME	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.8677003286755717
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000545554	0.8677003286755717
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000545554	0.8677003286755717
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.8677003286755717
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000545554	0.8677003286755717
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.8677003286755717
HYDRANENCEPHALY	0.000545554	0.8677003286755717
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.8677003286755717
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.8677003286755717
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.8677003286755717
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.8677003286755717
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.8677003286755717
ZECHI-CEIDE SYNDROME	0.000545554	0.8677003286755717
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000545554	0.8677003286755717
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.8677003286755717
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.8677003286755717
HYPERTRICHOSIS CUBITI	0.000545554	0.8677003286755717
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.8677003286755717
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.8677003286755717
ICF SYNDROME	0.000545554	0.8677003286755717
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.8677003286755717
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.8677003286755717
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.8677003286755717
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.8677003286755717
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.8677003286755717
NEPHROGENIC DIABETES INSIPIDUS	0.000545554	0.8677003286755717
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.8677003286755717
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.000545554	0.8677003286755717
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.8677003286755717
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.8677003286755717
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.8677003286755717
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.8677003286755717
HOLOPROSENCEPHALY	0.000545554	0.8677003286755717
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000545554	0.8677003286755717
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.8677003286755717
DONNAI-BARROW SYNDROME	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000545554	0.8677003286755717
COLE-CARPENTER SYNDROME	0.000545554	0.8677003286755717
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000545554	0.8677003286755717
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.8677003286755717
COWDEN SYNDROME	0.000545554	0.8677003286755717
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.8677003286755717
EAST SYNDROME	0.000545554	0.8677003286755717
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.000545554	0.8677003286755717
MEVALONIC ACIDURIA; MEVA	0.000545554	0.8677003286755717
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.8677003286755717
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000545554	0.8677003286755717
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.8677003286755717
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.000545554	0.8677003286755717
GALLOWAY-MOWAT SYNDROME	0.000545554	0.8677003286755717
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.8677003286755717
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000545554	0.8677003286755717
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.8677003286755717
NOONAN SYNDROME 3; NS3	0.000545554	0.8677003286755717
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.8677003286755717
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.8677003286755717
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.8677003286755717
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.8677003286755717
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000545554	0.8677003286755717
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.8677003286755717
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.000545554	0.8677003286755717
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000545554	0.8677003286755717
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.8677003286755717
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000545554	0.8677003286755717
GERODERMA OSTEODYSPLASTICA	0.000545554	0.8677003286755717
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000545554	0.8677003286755717
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.8677003286755717
GENITOPATELLAR SYNDROME; GTPTS	0.000545554	0.8677003286755717
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.8677003286755717
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000545554	0.8677003286755717
8P11.2 DELETION SYNDROME	0.000545554	0.8677003286755717
6Q25 MICRODELETION SYNDROME	0.000545554	0.8677003286755717
3Q29 MICRODUPLICATION SYNDROME	0.000545554	0.8677003286755717
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.8677003286755717
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.8677003286755717
MICRO SYNDROME	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.8677003286755717
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.8677003286755717
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.8677003286755717
LISSENCEPHALY 1; LIS1	0.000545554	0.8677003286755717
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.8677003286755717
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000545554	0.8677003286755717
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000545554	0.8677003286755717
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.8677003286755717
FUMARASE DEFICIENCY; FMRD	0.000545554	0.8677003286755717
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.8677003286755717
N SYNDROME	0.000545554	0.8677003286755717
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000545554	0.8677003286755717
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.000545554	0.8677003286755717
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.8677003286755717
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.8677003286755717
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.8677003286755717
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.8677003286755717
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.8677003286755717
PHACE ASSOCIATION	0.000545554	0.8677003286755717
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.000545554	0.8677003286755717
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.000545554	0.8677003286755717
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000545554	0.8677003286755717
CITRULLINEMIA TYPE II	0.000545554	0.8677003286755717
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.8677003286755717
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000545554	0.8677003286755717
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.8677003286755717
TRISOMY 9P	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.8677003286755717
JOUBERT SYNDROME 27	0.000545554	0.8677003286755717
JOUBERT SYNDROME 28	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000545554	0.8677003286755717
LARSEN-LIKE SYNDROME	0.000545554	0.8677003286755717
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.8677003286755717
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.8677003286755717
USHER SYNDROME TYPE 1	0.000545554	0.8677003286755717
ALAZAMI-YUAN SYNDROME	0.000545554	0.8677003286755717
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.000545554	0.8677003286755717
MICROVILLUS INCLUSION DISEASE	0.000545554	0.8677003286755717
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.8677003286755717
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.8677003286755717
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.8677003286755717
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.8677003286755717
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.8677003286755717
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.8677003286755717
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.8677003286755717
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.8677003286755717
MARDEN-WALKER SYNDROME	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.8677003286755717
RFT1-CDG	0.000545554	0.8677003286755717
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.000545554	0.8677003286755717
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.8677003286755717
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000545554	0.8677003286755717
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.8677003286755717
JOUBERT SYNDROME 2	0.000545554	0.8677003286755717
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.8677003286755717
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.000545554	0.8677003286755717
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000545554	0.8677003286755717
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.8677003286755717
